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ABSTRACT 
 
Down Syndrome (DS) is the most frequent autosomal aneuploidy that is 
compatible with post-natal life. The DS phenotype has been attributed to 
overexpression of chromosome 21 (Hsa21) genes. It is unknown which, and 
how many, chromosome 21 genes are responsible for each DS phenotypic sign 
such as mental retardation, cardiac defects, muscle hypotonia, immunological 
disorders, etc. Hsa21 trisomy has been associated to mitochondrial dysfunction 
in several DS cells and mouse models suggesting that a mitochondrial 
dysfunction contributes to DS phenotype. We demonstrated, by microarray 
analysis and by qRT-PCR, the global upregulation of Hsa21 genes and the 
dysregulation of genes located on other chromosomes in trisomic fetal hearts at 
18-22 weeks of gestation. Downregulation of genes encoding mitochondrial 
enzymes was a hallmark of trisomic fetal samples.  
Molecular, functional and morphological studies of mitochondria in primary 
lines of fetal fibroblasts were performed in order to evaluate the mitochondrial 
dysfunction associated to the dysregulation of mitochondrial gene expression 
in DS. 
Molecular analysis of trisomic fibroblasts demonstrated that the upregulation 
of chromosome 21 genes and the dysregulation of mitochondrial genes also 
occur in these cells, and that it is not identical to the one observed in fetal 
hearts. 
Functional studies demonstrated a significant reduction of the oxygen 
consumption rate and of respiratory chain complex I activity in trisomic 
fibroblasts, a decrease of mtDNA copy number and an increased production of 
reactive oxygen species.  
Furthermore, the mitochondria ultrastructure of trisomic fibroblasts, assessed 
by electron microscopy, revealed morphological abnormalities like giant 
mitochondria with irregular shape, evident breaks of both inner and outer 
membranes and an altered cristae pattern.  
These results are indicative of a widespread mitochondrial dysfunction in DS. 
To detect the earliest changes in gene expression profile, a new in vitro cell 
culture model was set up. Human stem cells from euploid as well as from 
Hsa21 trisomic fetuses were obtained. Both fresh and frozen amniotic fluid 
cultures were successfully used and the lines obtained appear to be suitable to 
study the differentiation processes in trisomic vs. euploid cells. 
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BACKGROUND 
1. Down Syndrome 
   Down Syndrome (DS) is the most frequent autosomal aneuploidy that is 
compatible with post-natal life. It results from complete or partial trisomy of 
chromosome 21 (Hsa21) and is characterized by a complex phenotype in which 
over 80 features occur with various degrees of expression and frequency 
[Epstein et al. 1991].  
Constant features in trisomic subjects are mental retardation, hypotonia, 
developmental delay, a partial immune deficiency, especially of thymus-
dependent system, and an increased risk of leukemia. 
Down syndrome is a major cause of congenital heart defects (CHD). It is 
associated mostly with endocardial cushion defects [Ferencz et al. 1989, Park 
et al. 1977], the most frequent being atrioventricular canal defects (AVCD) 
followed by ventricular septal defects (VSD) and tetralogy of Fallot [Park et al. 
1977].  
 
DS-CHD critical region 
   It has been known since half a century that Down syndrome is caused by the 
presence of an extra copy of chromosome 21. However, the molecular 
alterations that cause the DS phenotype are still elusive, despite a large amount 
of studies. Indeed, it is unknown which, and how many, chromosome 21 genes 
are responsible for each DS phenotypic sign such as mental retardation, cardiac 
defects, muscle hypotonia, immunologic disorders, etc. 
Several attempts to identify the Hsa21 genes that contribute to the DS 
phenotype have focused on the Down Syndrome Critical Region (DSCR) 
which spans approximately 5.4 Mb in band 21q22.3 (Fig. 1) [Korenberg et al. 
1994; Delabar et al. 1993; McCormick et al. 1989; Rahmani et al. 1989]. The 
DSCR hypothesis predicts that a gene, or some genes, in this region are 
sufficient to produce the specific DS features when present in three copies. A 
narrowed region from D21S3 to PFKL in 21q22.3 was also proposed as the 
candidate region for heart defects (DS-CHD region) [Barlow et al. 2001]. The 
DSCR hypothesis was tested in mice [Olson et al. 2004] and it was found that 
trisomy of DSCR alone is necessary but not sufficient for brain DS phenotypes 
in trisomic mice. These results suggest that the origins of trisomic phenotypes 
are even more complicated than formerly assumed and that they probably 
involve multiple gene interactions [Olson et al. 2007]. It has been proposed that 
the complex phenotypic alterations of DS could result from an interplay 
between Hsa21 genes and developmentally regulated genes elsewhere on the 
genome [Reeves 2001] and that the loss of genetic balance in pivotal processes 
regulating development might increase susceptibility to genetic and 
environmental insults [Shapiro 1997]. 
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Figure 1. Down Syndrome Critical Region. The DSCR spans approximately 
5,4Mb including bands 21q22.2 and 21q22.3 (pink area). This region presents 
with high gene density.  
 
 
Mouse models 
   To understand the molecular mechanisms of phenotypic alterations in DS, the 
mouse has been used extensively as a model organism, based on the syntenic 
conservation between human and mouse genomes. Hsa21 presents high 
sequence omology of about 30 Mb with mouse chromosome 16, including part 
of DSCR. Other sintenic regions are localized on murine chromosomes 10 and 
17.  
One group of mouse models was generated to carry Hsa21 or a fragment of it 
[O’Doherty et al. 2005, Shinohara et al. 2001]. The Tc1 model was obtained 
introducing into the mouse genome Hsa21 traits with only two small deletions 
including about 8% of Hsa21 genes. This mouse model shows craniofacial 
anomalies and cardiac alterations, typical of DS. The morphogenetic defects 
include ventricular and atrioventricular septal defect, that are due to an 
incomplete fusion of endocardial cushions [Dunlevy et al. 2010]. 
Another group of models carries three copies of mouse syntenic regions of 
Hsa21 in various sizes. Ts65Dn is the most widely used model from this group 
[Reeves et al. 1995]. Ts65Dn mice are trisomic for ~13.4 Mb of the Hsa21 
syntenic region on Mmu16, which contains approximately 99 orthologs of 
Hsa21 genes and exhibit only few phenotypic features comparable to DS. 
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Moore (2006) has found that ~8% of Ts65Dn mice develop septal defects 
which increase their post-natal mortality.  
In another mouse model, Dp(16)1Yu/+, the trisomic region spans from 21q11 
band to 21q22.3 band thus including part of DS-CHD region. These transgenic 
mice develop congenital cardiopathy with a similar percentage to those found 
in DS individuals [Li et al. 2007]: atrioventricular septal defects including 
Tetralogy of Fallot and atrioventricular canal defect. 
Mice trisomic for smaller regions of Mmu16 have also been described. The 
Ts1Cje mouse is trisomic for ~70 Mmu16 genes extending from, but not 
including, Sod1 to the Mmu16 telomere [Sago et al. 1998]. These mice showed 
distinct learning and behavioral deficits, probably caused by abnormalities 
within the hippocampus that result in abnormal hippocampal function. Olson et 
al. (2004) produced mice trisomic only for DSCR between Cbr1 and Mx1, 
containing roughly 33 annotated genes (Ts1Rhr mice), demonstrating that 
DSCR alone is necessary but not sufficient for brain DS phenotypes in trisomic 
mice, even though more recently Belichenko et al. (2009) demonstrated that 33 
genes mapping to the DSCR are responsible at least for 20 DS features in the 
mouse Ts1Rhr. 
Because of the potential species-specific differences between Hsa21 and the 
mouse syntenic regions, the transcriptional regulations of the Hsa21 gene 
orthologs and the interactions of the proteins encoded by these orthologs in a 
trans-species mouse mutant may be different from those in a mouse mutant 
carrying three copies of a mouse syntenic region, even if the triplicated regions 
carry the same orthologous genes in both mutants. Therefore, Yu et al. (2010) 
decided to generate a mouse model trisomic for all three Hsa21 syntenic 
regions and to analyze the impact of the simultaneous presence of the three 
segmental trisomies on the cognitively relevant phenotype. This mouse model, 
named Dp(10)1Yey/+;Dp(16)1Yey/+;Dp(17)1Yey/+, seems to be the more 
desiderable genotype for modeling human trisomy 21 and it shows the DS-
related abnormalities in the central nervous system, including impairments in 
learning and hippocampal LTP as well as hydrochephalus. There is no 
evidence of congenital cardiopathy in this model. 
In conclusion, all these models should facilitate better understanding of the 
mechanisms underlying developmental defects in DS as well as the 
development of new therapies for the clinical phenotype of the disorder but no 
one can be considered the perfect one. 
Gene expression in DS 
   It has been postulated that a triplicated chromosome 21 causes an increase in 
the expression of trisomic genes as a primary dosage effect. This primary 
dysregulation produces, as secondary effect, the dysregulation of genes 
mapping on different chromosomes causing the dysregulation of several 
proteins and consequently the DS phenotype (Fig. 2). 
In agreement with the above hypothesis, several studies have reported a 
generalized overexpression of triplicated genes at the mRNA level in mouse 
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models of DS [Amano et al. 2004; Lyle et al. 2004; Kahlem et al. 2004; 
Dauphinot et al. 2005]. Interestingly, studies performed on human trisomic 
tissues indicated that only a subset of Hsa21 genes is over-expressed relative to 
euploid controls and that the increase in expression may slightly differ from the 
expected ~1.5-fold [FitzPatrick et al. 2002; Mao et al. 2005, Conti et al. 2007]. 
Also, the set of over-expressed Hsa21 genes differs across the trisomic cell 
types [Li et al. 2006]. These findings indicate that other factors (e.g. 
developmental stage, tissue-specific differences) might also affect gene 
expression [Sommer and Henrique-Silva 2008]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Primary and secondary effects of trisomy 21. Three copies of 
Hsa21 may cause a 50% increase in the expression of trisomic genes as 
primary dosage effect. The abnormal mRNA levels of Hsa21 genes may cause 
alteration of disomic gene expression as secondary effects. Both primary and 
secondary effects will finally result in developmental defects and phenotypic 
alterations. 
 
A previous study performed in our laboratory on heart tissue [Conti et al. 2007] 
demonstrated that chromosome 21 genes were globally upregulated and that 
441 genes, located on other chromosomes, were significantly dysregulated in 
trisomic heart samples. Downregulation of genes encoding mitochondrial 
enzymes and upregulation of genes encoding extracellular matrix (ECM) 
proteins appeared to be a hallmark of trisomy 21 in fetal heart samples. Other 
studies agree with these findings: in fact, data from functional studies suggest 
that multiple chromosome 21 genes affect protein processing, mitochondrial 
function and reactive oxygen species production, one-carbon metabolism and 
cell adhesion [Gardiner 2003].  
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2. Mitochondrial dysfunctions in DS 
   Trisomy of chromosome 21 has been associated to mitochondrial 
dysfunction, in several DS cell [Busciglio et al. 1995; Roat et al. 2007] and 
mouse models [Shuchman et al. 2000; Shukkur et al. 2006], suggesting that a 
mitochondrial dysfunction contributed to DS phenotype. It has been 
hypotesized that the pathogenetic mechanisms may be ascribed to oxidative 
stress caused by reactive oxygen species (ROS) formation, to altered 
intracellular calcium homeostasis and to apoptosis. No molecular studies have 
been performed yet to investigate the bases of mitochondrial dysfunction at 
transcriptional level. 
Mitochondria: structure and function 
   Mitochondria are intracellular organelles present in the cytoplasm of all 
eukaryotic cells. The overall volume of mitochondria is high (thousands per 
cell) in tissues and organs with high metabolic activity such as brain, retina, 
skeletal muscle, heart, kidney, and endocrine glands. The overall volume of 
mitochondria further increases in cells with enhanced energy demands, as in 
hyperactive skeletal muscle or in cardiac myocyte hypertrophy.  
Mitochondria are variable in size, with a diameter of about 1 µm-close to that 
of a bacterial cell. The shape and number of these organelles are regulated by 
fission and fusion processes which vary depending on the function of the cell 
and tissue. Mitochondria are surrounded by outer and inner membranes that are 
consistent with their symbiontic origin. The outer membrane is smooth and 
permeable, whereas the inner envelope is highly folded and structured in 
cristae and offers the major permeability barrier to ions and molecules that 
traverse to the inner mitochondrial compartment by active transport. The two 
envelopes enclose an intermembrane space and an area inside the inner 
membrane, called matrix, where the basic mitochondrial macromolecular 
syntheses (DNA replication, transcription, and translation) take place (Fig. 3).  
 
                                  
Figure 3. The mitochondrion. Electron microscope and simplified images of 
mitochondria, showing structural organization of outer and inner membranes, 
intermembrane space, cristae and matrix. 
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The function of the mitochondria is identical in all eukaryotic cells and is 
essentially devoted to energy production by oxidative phophorylation 
(OXPHOS) process. The energy produced in the mitochondrion is transferred 
to the whole cell, where it is essential for all biochemical processes. The 
OXPHOS system is embedded in the lipid bilayer of the mitochondrial inner 
membrane and is composed by five multiprotein enzyme complexes (I–V) and 
two electron carriers – coenzyme Q and cytochrome c (Fig. 4). Mitochondrial 
OXPHOS constitutes the major cellular ATP-producing mechanism under 
aerobic conditions.  
 
 
Figure 4. OXPHOS system in mammalian mitochondria. Schematic 
illustration of respiratory chain complexes, constisting of multiple subunits, in 
the mitochondrial inner membrane.  
 
The multi-component structure of the OXPHOS network poses the question as 
to which step(s) is (are) critical in controlling the efficiency of the overall 
process. An understanding of this specific point, besides its interest in basic 
research, is also important for elucidating the aetiopathogenesis of a number of 
human diseases characterized by impairment in OXPHOS efficiency. Defects 
in oxidative phosphorylation are generally studied by the measurement of 
mitochondrial oxygen consumption (respirometric OXPHOS analysis) using 
the polarographic oxygen sensor [Gnaiger and Forstner 1983]. This analysis 
provides a screening approach that reflects not only derangement of membrane 
structure, but also defects of enzyme systems in membrane transport, 
dehydrogenases, electron transport, and coupled ADP phosphorylation 
[Gnaiger 2008]. 
A consequence of mitochondrial activity is the production of reactive oxygen 
species (ROS) that refers to a group of oxygen containing compounds with the 
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ability to react with reduced compounds. They comprise superoxide (O2--•), 
hydrogen peroxide (H2O2), and the highly reactive hydroxyl radical (•OH), 
although minor amounts of singlet oxygen can also be formed by cells. The 
initial product of the electron transport chain is O2--•, which is quickly 
transformed into H2O2 by the enzyme superoxide dismutase (SOD). H2O2 can 
be reduced to water by catalase or glutathione peroxidase or can be converted 
into •OH in presence of reduced transition metals (reduced copper or iron). 
The main source of O2--• are respiratory complexes I and III located at the inner 
mitochondrial membrane. These complexes generate a small amount of O2--• as 
a side product of electron transport during oxidative phosphorylation. O2--• is 
released into the matrix in the case of complex I and to both the matrix and the 
intermembranous space by complex III [Chen et al. 2003; Camello-Almaraz et 
al. 2006]. The relative importance of these sites in O2--• mitochondrial output 
depends on tissue and mitochondria respiratory status. 
 
Nuclear genes in mitochondrial biogenesis and morphology 
   With only 13 OXPHOS polypeptides encoded by mtDNA, most of the 
OXPHOS subunits (at least 70) are encoded by the nuclear genome. There are 
also several nuclear gene products that regulate mitochondrial gene expression. 
Different authors have provided important insight into the regulatory 
mechanisms that are involved in the transcriptional control of OXPHOS genes. 
The transcriptional regulatory network controlling the expression of nuclear 
and mitochondrial genes includes nuclear respiratory factor NRF-1 and NRF-2 
and mitochondrial transcription factor A (mtTFA). NRF1, first characterized as 
an activator of cytochrome c expression, acts not only on the genes that encode 
OXPHOS subunits but also on the rate-limiting heme biosynthetic enzyme, and 
on mtDNA transcription and replication factors. NRF1 is itself a binding 
partner for the transcriptional co-activator PGC1α (peroxisome proliferator-
activated receptor co-activator 1α). PGC-1α is a transcriptional coactivator that 
lacks DNA-binding activity but interacts with and coactivates numerous 
transcription factors, including nuclear receptors such as PPARγ and PPARα, 
estrogen receptor α, thyroid hormone, retinoid receptors, and hepatocyte 
nuclear factor-4α. PGC-1α also coactivates nonnuclear receptor transcription 
factors, such as NRF-1, to activate the expression of known target genes, 
including mtTFA, a factor that is critical for the initiation of mitochondrial 
DNA replication [Russel et al. 2004; Smeitink et al. 2001; Wu et al. 1999]. 
The functional versatility of mitochondria is paralleled by their morphological 
complexity. In certain cell types mitochondria are organized in networks of 
interconnected organelles. The ultrastructural changes in the architecture of 
mitochondria are due to differences that are established in the amount and form 
of the cristae, which result from folding of the inner membrane and can be 
either laminated or tubular, depending on the metabolic states of organelle. 
The ultrastructure and the reticular organization of the organelle are determined 
by mitochondria-shaping proteins that affect the equilibrium between fusion 
and fission processes. The two dynamin-like GTPase, MFN1 and MFN2 are 
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the main regulators of the mammalian mitochondrial outer membrane fusion 
[Santel and Fuller 2001]; OPA1, another GTPase, is a protein that promotes 
fusion and, as well as other proteins involved in the modification of 
mitochondrial morphology, is closely regulated by complex post-
transcriptional mechanisms that include proteolytic degradation [Liesa et al. 
2009]. OPA1 has also an interesting role in apoptosis in particular it is involved 
in changes affecting the cristae (cristae remodeling) in order to promote the 
mobilization of cytochrome c from intermembrane space to the cristae and 
possibly to the cytosol [Scorrano et al. 2002]; the size of tubular connections 
between the cristae (cristae junctions) is controlled also by a complex 
consisting of two isoforms of OPA1, one of which is generated by protease 
PARL [Frezza et al. 2006]. Another protein implicated in these mechanisms is 
the mitofilin (encoded by the gene IMMT), a transmembrane protein localized 
at the base of the cristae, whose down-regulation results in a drastic change in 
the organization of the inner membrane that appears as densely packaged 
concentric layers and free of tubular connections [John et al. 2005] 
 
Calcium signaling 
   The mitochondria are actively involved in the regulation of calcium signaling 
through its accumulation and release, as a result of physiologic stimuli. These 
organelles behave as a high-capacity, low-affinity transient calcium store. An 
important role in calcium signaling is covered by calcineurin/NFAT signaling 
pathway. NFAT is a Ca2+/calcineurin (CaN)-dependent transcription factor that 
has been implicated in the development and function of various organ systems, 
including the immune, endocrine, and cardiovascular systems [Crabtree and 
Olson 2002]. NFAT is exquisitely sensitive to the duration of the Ca2+ signal, 
which is explained by its activation mechanisms.  
In resting cells, phosphorylated NFAT resides in the cytosol. It is 
dephosphorylated by CaN in response to an increase in [Ca2+]i, resulting in 
unmasking of its nuclear localization signal (NLS) and its import into the 
nucleus. There, NFAT cooperates with other transcription factors to initiate 
transcription. Once [Ca2+]i returns to basal levels, glycogen synthase kinase-3β 
(GSK3β) and several other protein kinases, as DYRK1A (a gene mapping to 
Hsa21 and upregulated in fetal DS hearts), rephosphorylate NFAT, which 
promotes NFAT export from the nucleus (Fig. 5) [Kim and Usachev 2009]. 
Thus, NFAT-mediated transcriptional responses depend on the balance 
between the activities of CaN and NFAT kinases. Consequently, retaining 
NFAT in the nucleus requires continuous CaN activity and persistent [Ca2+]i 
elevation. 
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Figure 5. Calcineurin/NFAT signaling. The entry of calcium ions into the 
cell activates the enzyme calcineurin to remove phosphate groups (P) from 
NFATc factors in the cytoplasm, allowing NFATc to enter the nucleus and 
activate its target genes. However, once in the nucleus, the NFATc can be 
phosphorylated, and so returns to the cytoplasm. Arron et al. and Gwack et al. 
(2006) implicate the DSCR1 and DYRK1A proteins in regulating the levels of 
NFATc phosphorylation. 
 
 
 
3. Choice of a model for trisomy 21: stem cells 
   Even though information about the function of chromosome 21 genes is 
going to increase rapidly, the molecular alterations that cause the Down 
syndrome (DS) phenotype are largely unknown. The investigation of the 
molecular mechanisms by which trisomy 21 causes the phenotype is hampered 
by the lack of specific models. Transgenic mice have proved to be an imperfect 
model and human tissues at proper developmental stages are difficult to obtain. 
New models are needed to bypass these inconveniences and stem cells might 
represent an adequate opportunity. Stem cells can be derived from individuals 
affected by a specific genetic disorder, like trisomy of Hsa21, and can be 
induced to differentiate into cell types that represent a target of the disease, 
mimicking the specific developmental changes that occur in vivo and that 
contribute to the phenotype. 
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As a matter of fact stem cell models have already been proposed to study the 
alterations in neuron development that occur in DS. This has been done 
through the formation of aggregates of stem and progenitor cells, isolated from 
neural tissue, the neurospheres, that represent a relatively pure population of 
dividing cells at a specific stage of development [Bhattacharyya and Svendsen 
2003].  
The model we have choosen is based upon the availability of non embryonic 
pluripotent stem cell lines that can be studied at various stages of 
differentiation. It has been recently demonstrated that human pluripotent stem 
cells can be conveniently obtained from amniocyte cell cultures (hAFSC) and 
can be differentiated into many cell types, including cardiomyocytes, muscle 
cells and neurons [De Coppi et al. 2007]. The choice of hAFSC is also due to 
the fact that we have access to a large collection of frozen amniocyte cells from 
euploid fetuses as well as from trisomy 21 fetuses and from many other 
pathologic conditions (Bank of Fetal Biological Samples, University of Naples 
Federico II). 
The hAFSCs show characteristics of mesenchimal stem cells and, as such, they 
are able to differentiate along adipogenic, osteogenic, myogenic, endothelial, 
neurogenic and hepatic pathways [Siddiqui and Atala 2004]. Thus they are a 
broad-spectrum multipotent stem cells. Approximately 1% of the cells in 
cultures of human amniocentesis specimens obtained for prenatal genetic 
diagnosis express the surface antigens such as c-Kit (CD117), the receptor for 
stem cell factor or the stage-specific embryonic antigen (SSEA)-4 [Miyake et 
al. 1983]; the presence of these antigens allows the immunoselection with 
magnetic microspheres using specific antibodies.  
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AIMS OF THE STUDY 
 
The global downregulation of genes encoding mitochondrial enzymes and 
respiratory chain complex subunits, previously found in fetal hearts with 
chromosome 21 trisomy, have induced us to perform a molecular, functional 
and morphological study of mitochondria in primary lines of fetal fibroblasts, 
obtained from trisomic and euploid fetuses. The aim of this study was to 
analyze the mitochondrial defect associated with DS as consequence of the 
dysregulation of mitochondrial genes.  
Gene expression profile has been determined in trisomic and euploid samples 
by microarray and qRT-PCR analysis, with particular attention to genes 
involved in mitochondrial biogenesis and function. 
Functional study has been performed in collaboration with the Department of 
Biomedical Sciences of Foggia University. Measurements of oxygen 
consumption, OXPHOS complex activities, ROS production, membrane 
potential and mtDNA copy number were studied. Finally, in collaboration with 
the Centre for Electron Microscopy of Naples University, mitochondrial 
ultrastructure was analyzed on fibroblasts in order to define morphological 
changes. The results of these studies lead us to hypothesize possible 
pathophysiological mechanisms of mitochondrial dysfunction in DS.  
The second step of this work was to set up an in vitro cell culture model that 
would enable us to detect the earliest changes in gene expression profile 
occurring during differentiation of trisomic cells. The rationale for this 
approach is the fact that the study of the mechanisms by which trisomy 21 
causes the phenotype is hampered by the lack of appropriate models. We 
decided to take advantage of the fact that it has been recently demonstrated that 
stem cells can be obtained from amniocyte cell cultures (hAFSC). Thanks to 
collaboration with Prof. Paolo De Coppi at Padova University and Prof. 
Gabriella Rosi at Perugia University, we obtained hAFSCs from amniotic fluid 
of trisomic fetuses and from non-trisomic controls.  
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MATERIALS AND METHODS 
Samples 
Human heart tissues and primary lines of fetal fibroblasts were used for this 
study. All samples were explanted from fetuses after therapeutic abortion and 
were obtained from the Telethon Bank of Fetal Biological Samples at the 
University of Naples. According to protocols approved by our Institutional 
Ethics Committee heart tissues from fifteen human fetuses from 18- to 22-
week-gestation with and without Hsa21 trisomy were analyzed by DNA 
microarray: ten were trisomic for Hsa21; 5 non trisomic fetuses served as 
controls. Fetal fibroblasts obtained from skin biopsies of 8 human fetuses (4 
trisomic for Hsa21 and 4 non trisomic, table 1) were used for qRT-PCR 
evaluations and functional and morphological studies. 
 
Table 1. Primary lines of fetal fibroblasts used in the study 
 
N: control samples; DS: Down Syndrome samples; DC: samples derived from 
trisomic fetuses with cardiopathy; D: samples derived from trisomic fetuses 
without cardiopathy. 
 
RNA extraction and Quantitative Real-time PCR 
Total RNA from each sample was extracted using TRIzol reagent (Gibco/BRL 
Life Technologies, Inc., Gaithersburg, MD) and was reverse-transcribed using 
iScript cDNA Synthesis kit (Biorad). Real-time PCR was performed using iQ 
Supermix SYBR Green 2X on the Bio-Rad iCycler (www.bio-rad.com) 
according to the manufacturer’s protocols. PCR reactions were performed in 
triplicate. The primers (MWG Biotech, Ebersberg, Germany) used for 
amplification are listed in table 2. Primer pairs were designed using the Primer 
3 software (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi/) to 
obtain amplicons ranging from 100 to 150 base pairs. In order to test primer 
efficiency, serial dilutions of cDNAs generated from selected samples, that 
expressed target genes at a suitable level, were used to generate standard 
curves for each gene. GAPDH housekeeping gene was chosen as reference 
gene.  
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Table 2. Primer sequences of genes analyzed by qRT-PCR. 
 
 
 
Measurement of the respiratory activity in intact cells 
Cultured cells were gently detached from the dish by tripsinization, washed in 
PBS, harvested by centrifugation at 500g for 5 min and immediately assessed 
for O2 consumption with a high resolution oxymeter (Oxygraph-2k, Oroboros 
Instruments). About 5x106 viable cells/ml were assayed in 50 mM KPi, 10 mM 
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Hepes, 1 mM EDTA, pH 7.4 at 37°C; after attainment of a stationary 
endogenous substrate-sustained respiratory rate, 2 µg/ml of oligomycin was 
added. The rates of oxygen consumption were corrected for 2 mM KCN-
insensitive respiration. The respiratory control ratio (RCR) was obtained 
dividing the rates of oxygen consumption achieved before and after the 
addition of oligomycin [Piccoli et al. 2007]. 
 
Measurement of the mitochondrial respiratory chain complexes activity 
The specific activities of NADH: ubiquinone oxidoreductase (complex I) and 
cytochrome c oxidase (complex IV) were assayed spectrophotometrically on 
frozen–thawn and ultrasound-treated cells in 10 mM Tris, 1 mg/ml serum 
albumin, pH 8.0. Complex I was assayed (in the presence of 1 µg/ml of 
antymicin A plus 2 mM KCN) by following the initial 2 µg/ml rotenone-
sensitive rate of 50 µM NADH oxidation (ε340nm = 6.22 mM-1 cm-1) in the 
presence of 200 µM decylubiquinone (dUQ) as electron acceptor; the NADH-
ferricyanide reductase activity of complex I was measured in the presence of 
rotenone, antimycin A and KCN with 200 µM potassium ferricyanide from the 
oxidation of NADH. Complex IV was assayed by following (in the presence of 
antymicin A) the initial 2 mM KCN-sensitive rate of 20 µM ferro-cytochrome 
c oxidation under aerobic conditions. The activities were normalized to the 
initial cell number and to cellular protein content [Cela et al. 2010].  
Citrate synthase catalyzes the reaction between acetyl coenzyme A (acetyl 
CoA) and oxaloacetic acid (OAA) to form citric acid. Citrate synthase activity 
was assayed spectrophotometrically measuring the reaction between CoA-SH 
(CoA with a thiol group) and DTNB (5,5′-dithiobis(2-nitrobenzoic acid)) to 
form 5-thio-2-nitrobenzoic acid (TNB) that absorbs at 412 nm. 
 
Laser scanning confocal microscopy imaging of mitochondrial membrane 
potential and ROS in live cells 
Cells cultured on fibronectin-coated 35mm glass-bottom dishes were incubated 
for 10 min at 37°C with the following probes: 2 µM tetramethylrhodamine, 
ethyl ester (TMRE), to monitor mitochondrial membrane potential (mtΔΨ) or 
10 µM 2’,7’-dichlorodihydrofluorescein diacetate (H2DCF-DA) for detection 
of H2O2. Both probes were from Molecular Probes (Eugene, OR). Stained cells 
were washed with PBS and examined by a Nikon TE 2000 microscope (images 
collected using a 60X objective (1.4 NA)) coupled to a Radiance 2100 dual 
laser (four-lines Argon-Krypton, single-line Helium–Neon) confocal laser 
scanning microscopy system (Biorad). TMRE is a fluorescent lypophilic 
cations that accumulates electrophoretically in mitochondria. The red 
fluorescence of TMRE was analysed by exciting the sample with the He–Ne 
laser beam (λex = 543 nm). DCF-DA is a membrane permeant probe which is 
hydrolysed by intracellular esterases and converted to the ROS (mainly H2O2)-
reacting product dichlorofluorescein (DCF). The green fluorescence of 
oxidised DCF was analysed by exciting the sample with the Ar–Kr laser beam 
(λex = 488 nm). Confocal planes (18–20) of 0.2 µm in thickness were examined 
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along the z-axes, going from the top to the bottom of the cells. Acquisition, 
storage and analysis of data were made by using LaserSharp and LaserPix 
software from Biorad or ImageJ (NIH, USA-http://rsb.info.nih.gov/ij/). 
Correction was made for minimal background by repeating the procedure in a 
cell-free field. At least 20 cells were randomly selected from 8 to 10 different 
fields for each cell samples under the indicated conditions and statistically 
analysed [Cela et al. 2010]. 
 
Morphological analysis 
Fibroblasts from trisomic and euploid fetuses were fixed and embedded for the 
electron microscope, using agarose as an intermediate embedding medium 
[Hayat 1981; Kerstens et al. 2000]. In the petri dishes the cells were fixed with 
4% paraformaldehyde and 5% glutaraldehyde in PBS buffer (0.1M, pH7,3) for 
30’ at room temperature, then washed in buffer, scraped from culture plates 
and pelleted by centrifugation for 10 min at 2000g; the supernatant was 
discarded and the cells were resuspended in 1 ml of 2% liquid agarose at 65°C. 
Again, the reaction tube was centrifuged for 5 min at 1000g to concentrate the 
cells in agarose. The agarose-cell pellet was solidified in ice for 30 min, then 
the agarose cone was carefully taken out of the reaction tube and divided in 
small pieces (1 mm3). The agarose-cell blocks was post-fixed in osmium 
tetroxide (1% in PBS buffer) for 1 h at 4°C, dehydrated and transferred first in 
propylene oxide, then in a mixture of propylene oxide-Epon 1:1 and finally 
embedded in Epon resin. The Epon blocks were polymerized for two days at 
60°C and then sectioned with a diamond knife to give thin sections, 70-80 nm 
each; the sections were picked up on 200 mesh copper grids, stained with 
uranyl acetate (5% in 50% methanol) and Reynolds lead citrate [Reynolds 
1963] and observed by transmission electron microscope Philips 208S. 
Micrographs were acquired with a Mega View II Soft Imaging System camera. 
 
Stereological investigations 
Three N and three DS samples were analyzed for this study (BIO-21, BIO-23, 
BIO-27 and BIO-36, BIO-37, BIO-48, respectively). We used a stereological 
estimator, the “fractionator” method, to obtain a systematic and uniformly 
random sampling, which ensures that even for relatively small samples the 
error is so small that it may safely be ignored [Gundersen 2002].  
Stereology is a method for translating images 2-D data into 3-D quantitative 
morphological information (volumes, surface-area-length, numbers) [Weibel et 
al. 1966; Mayhew 1991; Mandarim-De-Lacerda 2003]. 
Fifty cells per sample were analyzed and for each cell the percentages of 
broken and branched mitochondria and mitochondria with concentric or 
longitudinal cristae were determined. Furthermore, for each sample 25 
micrographs were collected to evaluate the mitochondrial volume density 
(Vmt, relative volume of mitochondria on cell volume) and mitochondrial 
cristae volume density (Vmc, relative volume of mitochondrial cristae on 
mitochondria volume) [Weibel et al. 1966]. To this end, a regular point lattice 
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was placed random on each micrograph, by using ImageJ 1.43 software: the 
Vmt is obtained by differential counting of the points lying on mitochondrial 
surface and the total points lying on the micrograph; Vmc is obtained by 
differential counting of the points lying on mitochondrial cristae surface and 
the total points lying on the mitochondria surface.      
 
Isolation and culture of human amniotic fluid stem cells (hAFSC) 
Amniotic fluid samples were obtained from Department of Obstetrics and 
Gynecology of University of Naples Federico II. Four milliliter of amniotic 
fluid were cultured in Chang B/C medium (Irvine Scientific), 1% 
penicillin/streptomycin (5000 units/ml and 5000 mg/ml) and 1ml glutamine 
200mM (Gibco) in 35mm plates (BD Falcon). After 10 days, cells were 
harvested by trypsinization and incubated with a mouse monoclonal antibody 
(1µl/106 cells) to CD117 (c-Kit) or SSEA-4 (Santa Cruz Biotechnology). The 
positive cells were purified by incubation with magnetic Goat anti−mouse IgG 
Dynabeads (Dynal, Invitrogen), using a magnetic column (Dynal). Isolated 
hAFSCs were cultured in αMEM medium (Gibco, Invitrogen) containing 15% 
FBS, 1% glutamine and 1% penicillin/streptomycin (Gibco), supplemented 
with 18% Chang B and 2% Chang C at 37°C with 5% CO2 atmosphere. After 
6−7 days, clones of c-kit or SSEA-4 positive cells were visible. hAFSCs were 
subcultured and not permitted to expand beyond 70% of confluence. Cloned 
hAFSC cell lines were generated by the limiting dilution method in 96−well 
plates. 
 
Immunofluorescence and confocal microscopy 
Cells were fixed in 4% paraformaldehyde in PBS for 20 min, washed twice for 
5 min each time, with 50mM NH4Cl in PBS. The cells were then blocked in 
5% goat serum in PBS for 1 h and washed twice in PBS. Mouse monoclonal 
primary antibody anti-SSEA-4 (Santa Cruz Biotechnology) diluted 1 : 100 in 
PBS 1% goat serum for 1 h in a humidified atmosphere was used.The cells 
were then extensively washed in PBS before staining with secondary goat anti-
mouse Alexa Fluor 546 (Molecular Probe, Invitrogen Corporation, Carlsbad, 
CA, USA). Nuclei were counterstained with Hoechst 33258 (0.5 mg/ml in 
PBS) (Sigma Aldrich) for 10 min. Finally, the cells were washed in PBS and 
mounted on glass slides with PBS containing 50% glycerol. 
Immunofluorescence analysis was performed at a confocal laser scanner 
microscope (LSM 510; Zeiss, Göttingen, Germany). The lambda of HeNe laser 
was set at 543 nm. Fluorescence emission was revealed by BP 560–615 band 
pass filter for Alexa Fluor 546. Nuclei stained with Hoechst 33258 were 
acquired as non confocal images by mean of a light detector and 352/461 nm 
filter (UV light). Images were acquired at a resolution of 1024x1024 pixels.  
 
Flow cytometry  
Assays were performed using CY−N (DAKO) according to the manufacturer 
protocols. The cells (7x106) were detached from culture dishes by incubation 
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with Accutase (Invitrogen) and incubated with the following antibodies: CD29-
FITC, CD44-FITC, CD45-PE, CD117-PE (Immunotech, Beckman Coulter, 
Marseille, France); CD73 (BD Biosciences Pharmingen, Europe), CD105 
(Abcam), and SSEA-4 (Santa Cruz Biotechnology). Secondary antibodies were 
AlexaFluor546−goat anti−mouse IgG or AlexaFluor488−goat anti−mouse IgG 
(Molecular Probes / Invitrogen, Eugene, OR). To determine cellular viability, 
7-Amino-actinomycin D (AAD) (Immunotech, Beckman Coulter, Marseille, 
France) was used. 7-AAD intercalates into double-stranded nucleic acids and is 
excluded by viable cells but can penetrate cell membranes of dying or dead 
cells.  
 
Statistics 
The Student’s t-test was applied to evaluate the statistical significance of 
differences measured throughout the data-sets presented.  
Concerning stereological investigations, the data obtained from each samples 
were averaged per group (DS and N) and statistical evaluation was performed 
by two non-parametric statistical tests, the Kolmogorov-Smirnov and the 
Kruskal-Wallis tests.  
The threshold for statistical significance (p-value) was set to 0.05. 
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RESULTS 
1. Differential gene expression in DS hearts and in cultured fibroblasts 
   By comparing the gene expression profile of 10 human hearts from trisomic 
fetuses (DSH) to 5 fetal hearts of non-trisomic controls (NH), we previously 
demonstrated a global upregulation of Hsa21 genes and a dysregulation of 
about 400 genes localized on other chromosomes [Conti et al. 2007]. 
Functional analysis of the genes differentially expressed between trisomic and 
control samples showed global downregulation of genes encoding 
mitochondrial proteins, especially enzymes involved in the oxidative 
phosphorylation pathway [Conti et al. 2007].  
Based on these results we focused our attention on mitochondrial genes as 
potential candidates to favor or promote the cardiac phenotype observed in the 
DS. In particular we considered genes encoding transcription factors involved 
in mitochondrial gene regulation (NRF1, TFAM, and PPRC1), genes involved 
in oxidative phosphorylation processes (NDUFA13 and SLC25A4) and genes 
important for maintenance of mitochondrial shape and morphology (IMMT, 
OPA1 and PARL). Quantitative Real-Time PCR (qRT-PCR) experiments 
validated microarray analysis demonstrating the downregulation of NRF1, 
PPRC1, IMMT, NDUFA13 and SLC25A4 in DSH versus NH samples (Fig. 
6), while OPA1, PARL and TFAM were normoregulated. Analyzed genes and 
their expression ratios, obtained by microarray and by qRT-PCR, are listed in 
table 3.   
 
        
 
Figure 6. Expression of mitochondrial genes in DS hearts by qRT-PCR. 
Gene expression level of IMMT, NRF1, PPRC1, SLC25A4 and NDUFA13 
was determined by qRT-PCR in trisomic hearts (DSH, red bars) versus euploid 
hearts (NH, blue bars). Five hearts per group were analyzed. All genes were 
significantly downregulated in DS samples (p<0.05). 
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Table 3. Expression ratios of mitochondrial dysregulated genes in trisomic 
vs euploid samples 
 
 Gene name, probe set ID, Fold Change and qRT-PCR ratio are listed. 
 
Overall the microarray analysis indicated the downregulation of genes 
encoding all five complex subunits of OXPHOS process and of other genes 
implicated in mitochondrial biogenesis. This widespread dysregulation of 
mitochondrial genes suggested that the mitochondrial function could be also 
impaired. To investigate the presence of a mitochondrial dysfunction 
associated with DS, 8 primary lines of fetal fibroblasts derived from trisomic 
and euploid fetuses were chosen as cell model (table 1 in methods). It was 
ascertained that no changes in chromosome number and structure had occurred 
in the fibroblasts after thawing and culture passages: in fact, all trisomic 
fibroblasts showed three copies of Hsa21 as the only cytogenetic alteration 
(Fig. 7).   
 
 
 Figure 7. Karyotype of DS fetal fibroblasts 
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To confirm the upregulation of Hsa21 genes in DS versus control fibroblasts, 
the expression of Hsa21 genes was determined by qRT-PCR. In particular, 
Hsa21 genes BTG3, SOD1, ITSN1 and DYRK1A, were upregulated in 
trisomic fibroblast samples when compared to control samples (Fig. 8).  
 
                      
Figure 8. Expression of Hsa21 genes in fibroblasts by qRT-PCR. Gene 
expression level of Hsa21 genes in trisomic samples (DS fibroblasts, purple 
bar) versus euploid samples (Control fibroblasts, red bar). All analyzed genes 
were significantly upregulated in DS samples (p<0.05). 
  
The dysregulation of genes involved in mitochondrial function was then 
determined in fetal trisomic fibroblasts versus euploid samples, by qRT-PCR 
(Fig. 9). The results confirmed the downregulation of IMMT and NRF1, as 
observed in fetal hearts, while NDUFS3, UQCRC1, COX10 and PPRC1 were 
normoregulated and NDUFB8 and COX5A turned out to be upregulated in DS 
fetal fibroblasts versus controls. 
These results only partially confirm the overall dysregulation of genes 
encoding for mitochondrial proteins, as it was previously determined in human 
fetal hearts, indicating that different tissues or cells may undergo different 
mechanisms of transcription regulation.  
        
         
 
26 
 
                      
                      
                      
Figure 9. Expression of mitochondrial genes in fibroblasts by qRT-PCR. 
Gene expression level of mitochondrial genes in trisomic samples (DS 
fibroblasts, purple bar) versus euploid samples (Control fibroblasts, red bar) 
showed that only IMMT, NRF1, NDUFB8 and COX5A were significantly 
dysregulated (p<0.05), while NDUFS3, UQCRC1, COX10 and PPRC1 were 
not significantly altered (NS). 
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It has been demonstrated that the calcineurin(CaN)/NFAT signaling pathway 
has a critical role during heart development; for this reason we have previously 
evaluated the expression of the NFATc transcription factor family and of the 
catalytic subunits of CaN (PPP3CA, PPP3CB and PPP3CC) by microarray and 
qRT-PCR experiments on fetal hearts (Fig. 10). We found a significative 
downregulation of these genes in trisomic hearts [Conti et al. 2007]. 
Quantitative RT-PCR experiments have demonstrated that the NFATc 
expression was perturbated also in trisomic fetal fibroblasts. In particular 
NFATc2, NFATc3, NFATc4, were significantly (p<0.05) downregulated in 
trisomic fibroblast samples if compared to the control samples (Fig. 11). 
 
  
Figure 10. Expression of catalytic subunits of CaN in DS hearts by qRT-
PCR. 
Gene expression level of PPP3CA, PPP3CB and PPP3CC was determined by 
qRT-PCR in trisomic hearts (DSH, red bars) versus euploid hearts (NH, blue 
bars), showing a significative downregulation in DS samples (p<0.05). 
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Figure 11. Expression of NFATc transcription factors in fibroblasts by 
qRT-PCR.  
Gene expression level of NFATc2, NFATc3 and NFATc4 in trisomic samples 
(DS fibroblasts, purple bar) versus euploid samples (Control fibroblasts, red 
bar). All NFATc genes were significantly downregulated in DS fibroblasts 
(p<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
29 
 
2. Functional analysis of mitochondria in DS fibroblasts 
   To verify the hypothesis that the mitochondrial transcriptome dysregulation 
caused by Hsa21 trisomy might be responsible for mitochondrial dysfunction, a 
mitochondrial functional analysis in DS fibroblasts was carried out through 
several approaches: 1) measurement of endogenous respiration; 2) 
measurement of mitochondrial respiratory chain complexes activity; 3) 
production of Reactive Oxygen Species; 4) measurement of mitochondrial 
transmembrane potential (ΔΨm); 5) determination of copy number of 
mitochondrial DNA (mtDNA). 
Measurement of endogenous respiration 
   A typical output of respirometric measurements for oxygen consumption was 
first carried out on normal intact cells (Fig. 12). The respiratory rate was 
substained by endogenous substrates and relied almost completely on the 
mitochondrial contribution, as it was fully inhibited by KCN.  
The amount of the endogenous oxidizable substrates was apparently never 
limiting, since oxygen consumption was linear up to the instrumental detection 
limit (<5% oxygen saturation). By comparing the mean value of oxygen 
consumption (nmol/min/106 cells) of euploid versus trisomic samples, it was 
observed a 25% reduction (p<0.05) of respiratory activity in trisomic cells 
(Fig. 13A). 
Addition of the ATP synthase inhibitor oligomycin resulted in a marked 
decrease of the oxygen consumption rate, indicating an active phosphorylating 
State III for the endogenous respiration, but the differences between two 
groups were not significative (Fig. 13B). 
The final step was the addition of an uncoupler of the OXPHOS, FCCP (p-
trifluoromethoxy carbonyl cyanide phenyl hydrazone), a potent reversible 
inhibitor of mitochondrial oxidative phosphorylation able to depolarize 
mitochondrial membrane potential. In this condition, oxygen consumption rate 
was different (p<0.05) between DS and normal cells, with a reduction of about 
25-30% in trisomic samples, and the difference was statistically significant 
(Fig. 13C). 
 
                   
Figure 12. Schematic representation of polarographic assay.  
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Figure 13. Oxygen consumption in intact cells. Measurements of oxygen 
consumption rate in endogenous respiration condition (A), with the addition of 
oligomycin (B) and of FCCP (C). N: normal samples. DS: Down Syndrome 
samples. M: mean value. The differences in A and C conditions were 
statistically significant (p<0.05). NS: not significant. 
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Mitochondrial respiratory chain complexes activity 
   Spectrophotometric measurement of the activity of the mitochondrial proton 
pump respiratory complexes on solubilized cells revealed significative 
reduction (30-35%; p<0.05) of complex I in trisomic cells (Fig. 14A); 
conversely, the activity of complex IV was not significantly reduced (Fig.  
14B). For complex I and IV respectively, nmol of both NAD+ and reduced 
cytochrome c were measured. The citrate synthase activity was evaluated as 
internal reference of mitochondrial activity and cellular content. There was no 
statistical difference in citrate synthase activity between trisomic versus 
euploid samples (Fig. 14C). Normalization of individual complex activity on 
citrate synthase activity confirmed a significative reduction of complex I 
activity (Fig. 14D).   
 
 
Figure 14. Measurements of mitochondrial respiratory complex activity. 
Mitochondrial respiratory chain complex I (A) and IV (B) were measured in 
control (N) and Down Syndrome (DS) samples. Citrate synthase activity and 
normalization are shown in C and D respectively. The mean activity value of 
the two groups, DS versus N fibroblasts, was compared and only complex I 
activity was significantly different (p<0.05). M: mean value 
 
Results were also normalized on cellular protein content (mg/106 cells). 
Cellular protein content was measured in trisomic and euploid cells (Fig. 15A) 
showing a 15-20% increase in DS samples. The normalized data demonstrated:  
- a 20% reduction of citrate synthase (Fig. 15B) and complex IV activities 
(Fig. 15C) in trisomic cells, although not significative;    
- a 50% reduction (p<0.01) of complex I activity in trisomic cells (Fig. 15D); 
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- a 40-45% reduction of oxygen consumption in trisomic cells in 3 different 
conditions: endogenous activity (p<0.01), plus olygomicin (p<0.05) and plus 
FCCP (p<0.01) (Fig. 15E, F, G). 
 
 
Figure 15. Normalization of measurements by protein content. Protein 
content was measured in euploid and trisomic cells (A); citrate synthase (B) 
and respiratory chain complex (C, D) activities and oxygen consumption (E, F, 
and G) were normalized by cellular protein content. Mean values are shown. 
Differences in D, E, F and G were statistically significant (p<0.01 and p<0.05).  
N: control samples; DS: Down Syndrome samples. 
 
In conclusion, all these results suggest that in trisomic fibroblasts there is a 
respiratory failure, probably due to complex I deficiency that plays a critical 
role in controlling mitochondrial respiration. 
 
Production of Reactive Oxygen Species 
   Since the mitochondrial respiratory chain is known to be the major source of 
reactive oxygen species (ROS) within the cell, and complex I is considered one 
of the sites of generation of superoxide radicals [Kussmaul and Hirst, 2006; Li 
and Trush, 1998], the intracellular redox state was assessed by confocal 
microscopy using the fluorescent H2O2-sensitive probe dichlorofluorescein 
(DCF). Trisomic cells displayed in general a dotted green signal with higher 
intensity than euploid cells (Fig. 16A), indicating a more pronounced 
production of hydrogen peroxide. The dotted distribution of fluorescent signal 
clearly resembled the mitochondrial localization. Furthermore, a considerable 
increase of ROS production was observed in 2 out of 4 trisomic samples. These 
were the BIO22-DC and BIO36-DC samples that were derived from fetuses 
with cardiopathy. Measurements of mean fluorescence per cell of two sample 
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groups and the differences between averages, showed a ~3-fold increase of 
ROS production in DS versus N cells (Fig. 16B).  
 
           
Figure 16. ROS production by DS and control fibroblasts. A. Confocal 
microscopy images of DCF-H2O2 indicating mitochondrial localization of 
superoxide radicals (green signals). B. Mean fluorescence of DCF-H2O2 signal 
in euploid (gray bars) and trisomic samples (red bars). 
 
Measurement of mitochondrial transmembrane potential 
   The involvement of the membrane potential (ΔΨm) in the control of 
mitochondrial respiration in intact cells was directly assessed by laser-scanning 
confocal microscopy using the probe TMRE (Tetramethylrhodamine, ethyl 
ester). Depending on the extent of the transmembrane electrical potential, the 
dye accumulates in mitochondria and emits a red-orange fluorescence. The 
fluorescence signal due to accumulation of the probe in response to membrane 
potential was not significantly different between trisomic and euploid cells 
(Fig. 17A). The same result was obtained comparing the mean fluorescence per 
cell of the two sample groups (Fig. 17B). 
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Figure 17. Mitochondrial transmembrane potential determination. 
Confocal microscope images (A) and mean fluorescence values (B) of TMRE 
accumulation in mitochondria of trisomic (red bars) and euploid (gray bars) 
cells.  
 
Assessment of mtDNA copy number 
   The assessment of mtDNA copy number is a further method to evaluate 
mitochondrial properties and it is usually proportional to mitochondria cellular 
content. By qRT-PCR, it has been demonstrated that in trisomic cells, mtDNA 
copy number, calculated against nuclear DNA (nDNA) copy number, was as 
mean reduced of about 40%, if compared to euploid controls (Fig. 18). 
 
 
Figure 18. mtDNA copy number determination: mtDNA copy number of 
single sample and as mean are shown. N: normal samples; D: Down Syndrome 
samples.   
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3. Morphological and stereological analysis of mitochondria in DS 
fibroblasts 
   Electron microscopy of trisomic fibroblasts revealed that a large number of 
mitochondria showed an abnormal morphology, an increase in size, irregular 
shape and evident breaks of both inner and outer membranes. In addition, 
mitochondria of DS samples showed an altered pattern of cristae, that 
presented broadened and arranged concentrically or oriented in parallel to the 
long axis of the organelle (longitudinal cristae) (Fig. 19). 
The percentage of mitochondria with morphological abnormalities (breakage of 
the outer, inner or both membranes, branched mitochondria and with 
concentric or longitudinal cristae) has been evaluated in three DS and three 
euploid samples. Broken mitochondria and mitochondria with concentric and 
longitudinal cristae are significantly more abundant in trisomic samples than in 
the euploid samples. The difference was not significant for branched 
mitochondria (Fig. 20). 
Stereological analysis to determine the volume density of mitochondrial 
compartment, expressed as percentage of cellular volume, and of the cristae, 
expressed as percentage of mitochondrial volume, demonstrated that the 
mitochondrial volume density was comparable between trisomic and euploid 
samples (Fig. 21) while the cristae volume density in DS fibroblasts was 
significantly lower with respect to euploid controls (Fig. 22). 
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Figure 19. Electron micrographs of morphologically abnormal 
mitochondria in DS fibroblasts (A-J) and normal mitochondria in N 
fibroblasts (K, L).  
A and B: giant mitochondria; C and D: mitochondria with few and dilated 
cristae; E-G: broken and branched mitochondria; H: longitudinal cristae; I and 
J: concentric cristae; K and L: normal mitochondria in control fibroblasts. 
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Figure 20. Percentages of mitochondria with abnormal morphology in 
fibroblasts. 
The percentage of mitochondria that are broken or with concentric or 
longitudinal cristae is significantly higher in trisomic samples (DS) compared 
with euploid samples (N). No significant difference in the percentage of 
branched mitochondria. (Kolmogorov-Smirnov and Kruskall-Wallis test, p 
significant cut off <0.05). Mean values for DS and N samples ± standard error 
of the mean (SEM) are shown. 
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Figure 21. Mitochondrial volume density (%) relative to cell volume.  
The mitochondrial volume density is not significantly different between 
trisomic and euploid fibroblasts. In graph the mean values of mitochondrial 
volume density for DS and N samples ± SEM are shown. NS: not significant. 
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Figure 22. Mitochondrial cristae volume density (%) relative to 
mitochondrial volume.  
The mitochondrial cristae volume density value of trisomic fibroblasts is 
almost 50% of the value calculated in the euploid samples. In graph the mean 
values of mitochondrial cristae volume density for DS and N samples ± SEM 
are shown. (Kolmogorov-Smirnov and Kruskall-Wallis test, p significant cut 
off <0.05) 
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4. Isolation and characterization of hAFSC 
Selection of c-kit-positive AF cells 
   To generate a cell culture model from fetuses with trisomy of chromosome 
21, stem cells isolation from amniotic fluid was performed in collaboration 
with Dr. Paolo de Coppi at the Venetian Institute of Molecular Medicine 
(VIMM) of Padova. Twenty cultures of amniotic fluid cells were subjected to 
immunoselection with magnetic microspheres to isolate c-kit (CD117)-positive 
population (Fig. 23).  
 
                    
Figure 23. C-kit-positive isolated hAFC. Phase contrast image of hAFC after 
immunomagnetic selection of c-kit positive cells. 
 
Isolated cells were cultured to confluency not greater than 70% and grown to 
verify their proliferative potential. Immunophenotypic characterization was 
performed at passage 4 in non-tissue culture petri dish.  
Only 7 hAFC selections were able to reach passage 4 and the expression of 
appropriate markers, listed in table 4, was assessed by immunofluorescence 
and flow cytometry.  
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Table 4. Surface markers assessed in selected hAFC 
 
 
All the selections tested showed the enrichment of the stage-specific embryonic 
antigen SSEA4. C-kit-selected populations showed on average a 70% positivity 
to SSEA4 (Fig. 24) while the presence of c-kit on cellular membrane was never 
demonstrated.  
 
 
Figure 24. SSEA4 immunofluorescence of c-kit-positive hAFC. A: SSEA4 
positive cells in amniotic fluid culture; B: SSEA4 positive cells in c-kit-
selected hAFC; C: Enlargement of a single SSEA4 positive cell. Blue staining: 
Hoechst; red staining: mouse monoclonal antibody against SSEA4.  
 
Flow cytometry experiments using antibodies against several antigens 
demonstrated that selected hAFC showed, as mean, a marked positivity for 
SSEA4, CD105, CD29, CD73 and CD44; they were slightly positive for 
CD117 and negative for CD45. Percentages of positivity for each antigen are 
shown in Fig. 25. 
On the basis of these results, we concluded that it is possible to isolate c-kit-
positive cells by immunomagnetic selection and that these cells express several 
markers of stem cells [De Coppi et al. 2007]. C-kit antigen however is 
detectable neither by immunofluorescence nor by flow cytometry assays. 
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Figure 25. Surface marker expression of c-kit-selected hAFC by flow 
cytometry. Expression of surface antigens of cells labeled with specific 
antibodies: SSEA4-FITC (A), CD105-PE (B), CD29-FITC/CD45-PE (C), 
CD73-FITC (D), CD117-PE (E) and CD44-FITC (F). 
 
 
Selection of SSEA4-positive AF cells 
   As an alternative approach, hAFC were selected on the basis of the surface 
expression of SSEA4 antigen. Ten to twenty percent of amniotic fluid cells 
were positive for SSEA4 surface antigen. We tried to isolate these cells from 
amniotic fluid using a primary antibody against SSEA4. Twenty amniotic fluid 
cultures were subjected to immunomagnetic selection to obtain a SSEA4 
enriched cell population. The proliferative capacity in the selected SSEA4 
positive cultures was higher than that of the cells selected on the basis of the c-
kit positivity, as it has been possible to expand and characterize 10 of them. 
Flow cytometry assays demonstrated that SSEA4-selected cells showed 
generally high positivity for SSEA4, CD29, CD105 and CD73, while CD117 
was always undetectable (Fig. 26). 
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Figure 26. Surface marker expression of SSEA4-selected hAFC by flow 
cytometry. Expression of surface antigens of cells labeled with specific 
antibodies: SSEA4-FITC (A), CD105-FITC (B), CD29-FITC/CD73-PE (C), 
CD117-PE (D). 
 
To obtain a pure stem cell population, cloning of SSEA4-positive hAFC was 
performed by limiting dilution in 96-well plates. Most of the selected cells 
were unable to overpass 8 culture passages and rapidly lost their proliferating 
capacity, while continuing to express stem cell surface markers. 
The presence of c-kit mRNA was assessed by qualitative PCR. RNA was 
extracted from c-kit- and SSEA4-selected hAFC cultures and from an amniotic 
fluid culture not subjected to immunoselection. PCR demonstrated that the c-
kit transcript was indeed present (Fig. 27). Since the surface protein was 
undetectable by immunofluorescence and flow cytometry assays, it is likely 
that the protein either is unstable or does not reach the cell plasma membrane. 
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Figure 27. PCR analysis of c-kit mRNA. Lane 1: c-kit selected hAFC; lane 2 
and 4: control unselected cells; lane 3: SSEA4 selected hAFC. M: Molecular 
weight marker 
 
In conclusion these stem cells, obtained through immunomagnetic selection of 
c-kit and SSEA4 positive cells in amniotic fluid culture, were relatively simple 
to obtain but the following problems were noticed: 1-these cells were slow 
proliferating over 8 culture passages; 2-the immunophenotype was variable 
from one passage to another; 3-their cloning was difficult to obtain. 
 
Adhesion based hAFSC selection 
   An alternative approach to obtain hAFSC, based upon differential adhesion 
and an appropriate culture medium, has been successfully used by the Prof. 
Rosi’s group at the University of Perugia [Romani R. and Rosi G. personal 
communication]. 
These cells appeared as a homogeneous population, with a high proliferative 
potential and no karyotype anomalies or in vitro transformations even after 10 
culture passages. The immunophenotypic and molecular characterization by 
flow cytometry and RT-PCR respectively is shown in table 5.  
Profiling of surface markers and proliferation potential suggested that these 
cells could be used as model to investigate the molecular mechanisms by which 
trisomy 21 causes the phenotype. Two trisomic and 4 euploid cell lines have 
been obtained from fresh amniocyte cultures. 
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Table 5. Characterization of hAFSC obtained from adhesion based 
selection 
 
 
 
The possibility to obtain hAFSC from frozen amniocytes was also tested since 
many frozen samples of amniocytes with different chromosomal disorders are 
available at the Bank of Fetal Biological samples (University of Naples, Dpt of 
Biology and Pathology, Cellular and Molecular). Nine frozen amniocytes from 
trisomic fetuses were used and from 3 of them hAFSCs were obtained with 
properties similar to the ones selected from fresh cultures. 
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DISCUSSION 
A preliminary study performed in our laboratory, comparing DS fetal heart 
tissues to control heart tissues [Conti et al. 2007], demonstrated that 
chromosome 21 genes were globally upregulated and that 441 genes, located 
on other chromosomes, were significantly dysregulated in trisomic heart 
samples, supporting the hypothesis that genes outside Hsa21 play a role in 
determining DS features.  
Functional analysis of the genes differentially expressed between trisomic and 
control samples showed global downregulation of nuclear genes encoding 
mitochondrial proteins, especially enzymes involved in the oxidative 
phosphorylation pathway. Genes from all five complexes were downregulated 
suggesting that the corresponding proteins and enzymatic activities might be 
reduced, and that the mitochondrial function might be consequently impaired. 
For this reason we have conducted a molecular, functional and morphological 
analysis in primary cell lines of fetal fibroblasts, obtained from trisomic and 
euploid fetuses at about 20 weeks of gestation. 
Mitochondrial function and reactive oxygen pathways have been investigated 
by other authors with respect to neurodegeneration. Protein levels of 
mitochondrial complex I, III and V were found to be decreased in cerebellar 
and brain regions of DS subjects [Kim et al. 2001], and a reduction of 
mitochondrial enzyme activity has been reported in platelets from DS patients 
[Prince et al. 1994]. Moreover, impaired mitochondrial function, indicated by 
reduced mitochondrial redox activity and membrane potential, has been 
observed in DS astrocytes and in primary cultures of DS fibroblasts [Arbuzova 
et al. 2002, Busciglio et al. 2002]. More recently it has been also reported that 
the brain of the DS mouse model Ts1Cje shows decreased mitochondrial 
membrane potential and ATP production [Shukkur et al. 2006]. These results 
are indicative of widespread mitochondrial dysfunction in DS.  
 
Dysregulation of mitochondrial genes 
   Microarray data analysis performed in our study demonstrated that several 
genes involved in mitochondrial biogenesis and function were downregulated 
in trisomic fetal hearts at 18-22 weeks of gestation when compared to euploid 
hearts. We focused our attention on some of these genes, namely: NRF1, 
IMMT, PPRC1, NDUFA13 (GRIM19) and SLC25A4 (ANT1), and confirmed 
their downregulation in fetal heart tissue by qRT-PCR. Quantitative RT-PCR 
experiments confirmed the downregulation of NRF1 and IMMT genes also in 
fetal fibroblasts. SLC25A4 was not evaluated in fibroblasts because this is a 
cardiac-specific isoform of adenine nucleotide translocator. 
NRF-1 is involved in the transcriptional control of mitochondrial biogenesis 
during adaptive thermogenesis through its interaction with the cold-inducible 
coactivator PGC-1. The targeted disruption of the NRF-1 gene in mice 
established that NRF-1 is essential for early embryogenesis in mammals, and 
its loss of function resulted in a peri-implantation lethal phenotype. In addition, 
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loss of NRF-1 determined a dramatic decrease in the amount of mtDNA in the 
blastocyst, thus providing the first evidence that NRF-1 is required for 
mitochondrial maintenance of the respiratory apparatus [Huo et al. 2001]. 
NRF1 downregulation both in DS hearts and fibroblasts might be responsible 
for about 40% mtDNA copy number decrease. 
IMMT is a critical protein for maintenance of mitochondrial cristae 
ultrastructure and is involved in the stability of the whole mitochondria 
structure; its downregulation is responsible for abnormalities of the inner 
membrane and it has been speculated that these structural alterations may 
precede abnormal function, such as the hyperpolarization of the inner 
membrane and ROS iperproduction [John 2005]. 
PPRC1 or PRC is a member of the PGC-1 gene family that is expressed in 
organs with a high energy demand, especially in actively proliferating cells. It 
is a key trascriptional regulator of the fatty acid β -oxidation (FAO) pathway 
which is the principal source of mitochondrial ATP in the heart. PGC-1 plays a 
role in determining the metabolic phenotype of mitochondria among 
specialized cell types. It is possible that the availability of PGC-1 partners in a 
given tissue, such as NRF-1, PPARα, PPARγ, and other not yet identified, 
transcription factors dictate the level of expression of enzymes and proteins in 
specific mitochondrial pathways. This notion is supported by the observation 
that PGC-1 is capable of inducing either uncoupled or coupled respiration in a 
cell type–specific manner. Taken together, these findings suggest that PGC-1 
controls mitochondrial functional capacity in a tissue-specific manner [Wu et 
al. 1999; Lehman et al. 2000]. 
GRIM-19 (Genes associated with Retinoid–IFN-induced Mortality-19) was 
originally identified as an interferon (IFN)-β and retinoic acid (RA)-inducible 
gene with apoptotic effects in human cancer cell lines [Angell et al. 2000]. 
However, it was subsequently found to copurify with mitochondrial 
NADH:ubiquinone oxidoreductase (complex I) in bovine heart [Fearnley et al. 
2001]. By gene targeting in mice, it was further demonstrated that GRIM-19 is 
localized in complex I and it is essential for complex I assembly and electron 
transfer activity [Huang et al. 2004]. Various biological functions of GRIM-19 
have been revealed. Knockout of GRIM-19 in mice caused early embryonic 
lethality, indicating its essential role in the embryonic development [Huang et 
al. 2004]. Further studies in Xenopus demonstrated that GRIM-19 is necessary 
for early heart development by regulating Ca2+ homeostasis and the Ca2+-
dependent NFAT signaling pathway [Chen et al. 2007]. Furthermore, Lu et al. 
(2008) demonstrated that GRIM-19 has a unique role in the maintenance of 
ΔΨm, that overlaps its electron transfer activity. 
SLC25A4 or ANT1 encodes the adenine nucleotide translocator-1, playing an 
important role in the regulation of the intracellular energetic balance, and 
facilitates the exchange of extramitochondrial adenosine diphosphate (ADP) 
and intramitochondrial adenosine triphosphate (ATP). ANT1 is primarily 
espressed in heart and in skeletal muscle. Mutations and dysfunction of the 
ANT1 isoform result in severe cardiac and muscular disorder, impressively 
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shown in the knockout mice generated by Graham et al. (1997). Hearts from 
ANT1 null mutants revealed cardiac hypertrophy and developed pronounced 
characteristics of mitochondrial myopathy and cardiomyopathy with restricted 
oxidative phosphorylation, massive mitochondrial proliferation, and 
disarrangement of myofibers. In addition, knockout of ANT1 was associated 
with increased mitochondrial oxidative stress shown by elevated H2O2 
production, increased mitochondrial DNA mutations, and an activated 
detoxification enzyme system [Esposito et al. 1999].  
In conclusion, the downregulation of NRF1, IMMT, PPRC1, GRIM19 and 
ANT1 in DS fetal heart tissues and the downregulation of NRF1 and IMMT 
genes in DS fetal fibroblasts might account for mitochondrial dysfunctions, 
morphological changes and mtDNA copy number reduction as discussed in the 
next sections. 
 
Mitochondrial dysfunction in trisomic fibroblasts 
   Oxidative stress is a phenotypic hallmark in several genetic disorders 
characterized by cancer predisposition and/or propensity to premature ageing. 
Mitochondria have a key role in oxygen metabolism and subsequently they are 
the major source of ROS formation. Studies on mitochondrial function have 
focused so far on neurological appearance, suggesting that neurological 
disorders, including mental retardation in DS, are associated to mitochondrial 
dysfunction [Kim et al. 2001; Prince et al. 1994; Busciglio et al. 2002; Shukkur 
et al. 2006].  
Our study, in turn, focused on the cardiac phenotype of DS, showing a 
dysfunction in tissues other than brain and associating it with the expression 
profile of key genes.   
Respirometry experiments conducted in this study demonstrated that oxygen 
consumption rate was significantly reduced both in basal respiration condition, 
and in uncoupled state. The analysis of individual complexes showed a strong 
reduction in the activity of complex I, and a decrease in activity of complex IV 
in DS fibroblasts. It was also found a strong decrease of mtDNA copy number. 
It can be assumed, therefore, that in fibroblasts derived from trisomic fetuses 
there is a respiratory failure, possibly associated with a reduction of complex I 
activity which controls to the largest extent the respiratory activity. The two 
events, respiratory depression and deficit of complex I, do not show a direct 
correlation due to several compensatory mechanisms. 
A complex I deficiency is characteristic of mitochondrial diseases, as an 
isolated defect or, in most of cases, as a part of multiple respiratory chain 
deficiencies. Isolated complex I deficiency has been associated with a wide 
spectrum of symptomatic phenotypes, varying from fatal infantile lactic 
acidosis to some cases of Leigh’s disease, adult onset exercise intolerance, and 
some neurodegenerative diseases as Leber’s hereditary optic neuropathy 
(LHON), focal dystonia, and Parkinson’s disease. Experiments on cell lines 
and on isolated mitochondria have shown that inhibition of complex I with 
rotenone causes a reduction of cell growth, an increase in the ROS production 
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associated with an increased peroxidation of mitochondrial membrane and a 
reduction of membrane potential due to the reduction of the extrusion of 
protons in the intermembrane space [Barrientos et al. 1999]. The decrease in 
complex I was also found in mouse models with trisomy of chromosome 16 
and results were similar to those obtained from models of Parkinson's disease, 
suggesting that different neurodegenerative diseases may be associated to the 
same mitochondrial dysfunction [Bambrick et al. 2008].  
Redox imbalance demonstrated in DS cells might also be secondary to 
overexpression of copper-zinc superoxide dismutase (SOD1), as we found in 
trisomic fibroblasts by qRT-PCR. Neuronal death in DS has been linked to the 
triplicated expression of SOD1, which was suggested to be involved in the 
oxidative damage to neurons [Lee et al. 2001]. Furthermore it has been 
demonstrated that in fibroblasts from DS patients there was a defective repair 
of oxidative damage to mtDNA [Druzhyna et al. 2008] and that neurons of 
Ts16 mouse model had an increased  O2--• basal generation, possibly attributed 
to a complex I deficiency [Schuchmann  and Heinemann 2000]. This last 
consideration might be another cause of mtDNA copy number reduction. 
In this study we demonstrated not only that in fetal fibroblasts ROS production 
was ~3-fold increased in DS cells versus euploid controls, but that interestingly 
ROS were also significantly increased in fibroblasts from DS fetuses with 
cardiopathy if compared to controls. 
 
Morphological abnormalities of mitochondria in trisomic cells 
   Morphological analysis of mitochondria that we have performed in fetal 
fibroblasts derived from trisomic and euploid fetuses demonstrated that 
ultrastructural changes occur in mitochondria of DS samples. In particular, we 
found an increase in size or giant mitochondria with irregular shape and 
evident breaks of both inner and outer membranes. In addition, mitochondria of 
DS samples showed an altered pattern of cristae, that presented broadened and 
arranged concentrically or longitudinally to the organelle. Broken mitochondria 
and mitochondria with concentric and longitudinal cristae were significantly 
more abundant in trisomic samples than in euploid samples, but the difference 
was not significant for branched mitochondria. Stereological evaluations of 
mitochondrial volume density and cristae volume density in the same samples 
demonstrated that cristae volume density was significantly reduced in trisomic 
fibroblasts while there was no significant difference in mitochondrial volume 
density between trisomic and euploid cells. 
These results further expand evidences obtained mainly on brain tissues from 
other authors. Ultrastructural abnormalities like an unusual branched 
morphology of mitochondria in cultured cerebellar neurons from Ts16 mice 
were reported by Bersu et al. (1998). Shukkur et al. (2006) described an 
increased number of abnormal mitochondria, especially with broken cristae, in 
brain tissue of Ts1Cje mice.  
Mitochondria undergo regulated fusion and division, which appear to play key 
roles in establishing and maintaining mitochondrial shape. In certain cell types 
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mitochondria are organized in networks of interconnected organelles, 
depending on the equilibrium between fusion and fission. These mechanisms 
are susceptible to cellular metabolic needs and they influence not only cristae 
pattern but also the number and structure of tubular connections between them 
(cristae junctions) and between cristae and periferic portion of inner 
membrane.  
The molecular mechanisms governing the biogenesis and configuration of the 
inner membrane are largely unknown. John et al. (2005) demonstrated that the 
downregulation of mitofilin resulted in a drastic change in the organization of 
the inner membrane that formed concentric layers instead of organizing into 
tubular cristae. In this study we demonstrated that mitofilin (IMMT) is 
downregulated both in trisomic hearts and fibroblasts. Furthermore, electron 
microscope observations revealed that the inner membrane of trisomic 
fibroblast mitochondria formed concentric layers. Cristae formation is critical 
for achieving high surface-to-volume ratio of the inner membrane. Although 
the concentric layering increases the inner membrane surface area, the tightly 
packed membranous sheets and internal compartmentation might hinder 
exchange for ions and metabolites, possibly leading to altered membrane 
potential and ROS production as well as defective oxidative phosphorylation.  
For the first time, an abnormal mitochondrial ultrastructure has been observed 
in DS samples associated to IMMT downregulation. 
 
Calcineurin/NFATc signaling in trisomic samples 
   We demonstrated, both by microarray and by qRT-PCR, that the pathway of 
calcineurin/NFATc, a critical regulator of vertebrate development and 
organogenesis, was dysregulated in trisomic hearts and fibroblasts, being 
DYRK1A upregulated in DS samples while catalytic subunits of calcineurin 
(not yet evaluated in fibroblasts) and NFATc2, NFATc3 and NFATc4 were 
significantly downregulated. Moreover, NFAT gene regulation is deeply 
affected by the abundance of DSCR1/RCAN1, a gene mapping to Hsa21. 
Microarray data in DS heart tissues showed that DSCR1 expression is variable 
but it is always inversely correlated to NFAT gene expression. The expression 
variability of these genes might be ascribed to the evidence that 
calcineurin/NFATsignalling is only required for brief and sharply defined time 
windows during embryonic development. 
It might be useful to assess the expression of both catalytic and regulatory 
subunits of calcineurin in trisomic fibroblasts and regulatory subunits in 
trisomic hearts.  
It has been demonstrated that in Nfatc3-/-; Nfatc4-/- cardiomyocytes the 
enzymatic activity of complex II and IV of the respiratory chain and 
mitochondrial oxidative activity were reduced and mitochondria were swollen, 
with an abnormal cristae pattern [Bushdid et al. 2003], suggesting that the 
calcineurin/NFAT pathway affects mitochondrial activity and morphology 
during heart development.  
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A key issue of DS pathogenesis is to understand how upregulation of Hsa21 
genes dysregulates genes on different chromosomes, in this case genes 
encoding mitochondrial enzymes. 
Recent data suggest that perturbation of NFATc genetic regulatory circuit by 
an increased dosage of DSCR1 and/or DYRK1A, both mapping to Hsa21, may 
explain many of the developmental phenotype in Down Syndrome, especially 
cardiac defects. Nfatc2-/-; Nfatc3-/-; Nfatc4-/- triple-knockout mice showed, in 
presence of Dyrk1a and Dscr1 overexpression, phenotypic anomalies that 
resembled those observed in human DS and 65% of Nfatc1-4 and 
Cnb1(ortholog gene of calcineurin regulatory subunit PPP3R1) -null mice had 
endocardial cushion defects [Arron et al. 2006]. According to our results, we 
propose that upregulation of DYRK1A and/or DSCR1 in DS might affect the 
expression of mitochondrial proteins, and therefore mitochondrial function in 
trisomic hearts and fibroblasts, through the calcineurin/NFAT pathway. 
 
Establishment of a new model to study molecular bases of DS feature 
   An aim of this study was to isolate stem cells from amniocytes of euploid and 
of trisomy 21 fetuses, either from fresh amniotic fluid either from frozen 
culture samples. Indeed, there is the evidence that most of phenotypic features 
of DS are determined very early during organ differentiation. Neuronal 
precursors, for instance, show a reduced capability to generate normal 
differentiated neurons [Mensah et al. 2010] both in DS subjects and mouse 
models. The analysis of human hearts from DS embryos at 10 gestation weeks 
revealed a retardation of development in all hearts even though heart defects 
are detectable at birth in only 40-50% of DS subjects [Gittenberger-de Groot et 
al. 2003]. 
One methodology to isolate stem cells is based on the fact that stem cells in 
primary cultures of amniotic fluid express several specific antigens on their 
plasma membrane. We performed immunoselection of amniotic fluid stem 
cells (hAFSc) with magnetic microspheres using antibodies against membrane 
antigens, such as c-Kit (CD117) and SSEA-4. SSEA-4 is a stage-specific 
embryonic antigen that is a expressed by ES cells but generally not by adult 
stem cells, and is expressed in human amniotic fluid stem cells. C-Kit selection 
has already demonstrated to allow the isolation of clonal multipotent stem cell 
lines, positive for mesenchymal markers and negative for hematopoietic 
markers [De Coppi et al. 2007].  
Both immunoselections proved to be effective and cells enriched in 
mesenchimal and/or neural stem cell markers, such as SSEA4, CD105, CD29, 
CD73 and CD44, were obtained. However, cells immunoselected for either 
marker (CD117 or SSEA-4) turned out to be negative for CD117, either by 
flow cytometry either by immunofluorescence analysis. It has been puzzling to 
us for some time the fact that cells immunoselected for CD117 were then 
negative for the expression of that same marker. It turned out that mRNA for 
CD117 was indeed expressed by selected cells, suggesting that the CD117 
protein might be expressed on the plasma membrane only in a limited window 
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of time, in the cell life span. It is interesting to note that although both CD117 
and SSEA-4 marker immunoselection yielded cells that expressed the same 
markers, there was variability in the level of expression of each of them. This 
result might be in agreement with the fact that different types of mesenchimal 
stem cells were suggested to be present in the amniotic fluid [Siegel et al. 
2007]. 
A major question that arises from this study is whether the cells enriched by 
either immunoselection were bona fide stem cells. By definition a stem cell 
should be able to keep a high proliferative potential in the undifferentiated state 
and should be able to differentiate in one or more differentiated cell type(s) 
upon appropriate induction. On the other side a characteristic of stem cells is 
the expression of a specific panel of membrane antigens. The cells that we 
obtained by CD117 or SSEA-4 immunoselection manifested this last property 
but we have not been able to prove a high proliferative rate for any of the 
cultures that were prepared. We neither managed to clone any of them, which 
might be needed for our studies, since human amniotic fluid might contain 
more than one stem cell type [Siegel et al. 2007]. Of course this failure might 
be due to inappropriate culture conditions, such as inappropriate substrate or 
culture medium. 
Cells with stem cell properties, with respect to the expression of membrane 
markers (see table 5) and with long life span, were made available to us. It was 
also possible to obtain these stem cells from trisomic samples. This was 
relevant since stem cells have not yet been isolated from trisomy 21 amniotic 
fluid samples, though a preliminary study demonstrated that cells from those 
samples normally expressed stem cell markers [Prusa et al. 2003]. Stem cells 
were also obtained from frozen amniocytes derived from trisomic fetuses. This 
represents an important progress since we were able to use samples stored in 
the Bank of Fetal Biological Samples, which has been set up, over the years, in 
our own Department. Amniocyte samples from fetuses affected by other 
diseases are stored in the Bank unveiling the possibility to set up more cell 
models of human pathologies. What can be done with these cell models? They 
may provide a new source for the development of new approaches for stem cell 
therapies and tissue engineering, such as the surgical repair of congenital 
anomalies in the perinatal period and pathologies that might occur in the adult 
life. But, of course, they can be used for basic research on human genetic 
diseases and to design new therapeutic approaches in the near future [Siegel et 
al. 2007].  
With regard to our trisomy 21 cell model, there is of course a need for further 
characterization of the cell cultures, cloning if possible and monitoring the 
karyotype and the telomere length, to verify that cells are not altered after 
several passages in culture. In order to systematically evaluate primary 
dysregulations already occurring at the stage of stem cells, due to trisomy of 
chromosome 21, gene expression profiles from clonal hAFSCs obtained both 
from trisomic and euploid fetuses will be compared. Next step will be to 
differentiate stem cells in cell populations that are considered to be target of the 
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DS. Several tissues and organs are indeed target of DS. We plan to primarily 
address the study of the two tissues that are known to be the main targets of 
DS: the brain and the heart, and therefore we will promote neural and cardiac 
differentiation of trisomic stem cells. Gene expression profiles of differentiated 
cells obtained both from trisomic and euploid hAFSCs will be compared. The 
rationale for this analysis resides in the fact that many phenotypic features of 
DS are determined very early in development, when the tissue specification is 
not completely established. Our aim is to determine how many and which 
chromosome 21 genes are already dysregulated in the very early steps of 
differentiation and whether specific categories of genes are dysregulated, such 
as mitochondrial enzymes or extracellular matrix proteins, that we found 
dysregulated in a previous study performed on fetal heart tissue [Conti et al. 
2007]. 
Hsa21 trisomic stem cells can be also used as a model to test the significance 
of individual genes in determining the molecular basis of gene dosage 
imbalance in the most clinically relevant and common forms of aneuploidy. 
We could take a complementary approach to the one that was taken by De 
Cegli at al. (2010) who developed a mouse embryonic stem (ES) cell bank of 
human chromosome 21 genes. The human chromosome 21-mouse ES cell bank 
included 32 human chromosome 21 genes, which could be overexpressed in an 
inducible manner. Each clone was transcriptionally profiled in inducing versus 
noninducing conditions to evaluate the contribution of single genes to the 
trisomic mouse ES cell transcriptome. We are going to generate a similar bank 
of human pluripotent trisomic stem cells in which individual Hsa21 genes 
might be selectively inactivated to assess their contribution to the altered 
trisomic cell transcriptome. 
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Abstract: Background: Brain dead patients are the main source of organs for transplants. Brain death causes changes in 
peripheral organs. We define modifications of gene expression in specific pathways occurring in donor livers and their 
influence on gene expression profile of livers after transplant. 
Methods: We compared gene expression profile of both deceased donor livers and transplanted livers to gene expression 
data of liver tissue, retrieved from Array Express database, used as control. All expression data were obtained by 
microarray analysis. 
Results: The expression of about 33,000 genes has been compared in liver samples from three groups: deceased donor 
livers, transplanted livers two hours after reperfusion, and control livers. We found that about 900 genes are dysregulated 
in deceased donor versus control livers. Up-regulated genes are mainly involved in apoptosis, immune response and 
inflammation. Down-regulated genes are mostly involved in metabolism and electron transport. We also re-evaluated a 
group of genes that in a previous study were found dysregulated in transplanted livers when compared to donor livers. 
Most of these genes, but not all, were dysregulated also when compared to control livers. Moreover 317 additional genes, 
dysregulated after liver transplant, were identified in this study; they were undetectable in the previous study because. 
They had the same dysregulation both in donor and in transplanted livers. 
Conclusions: Understanding molecular mechanisms that in the donor compromise graft function is crucial in order to 
discriminate between basal graft damages and ischemia-reperfusion injuries and therefore to identify therapeutic targets 
aiming to improve liver transplantation performances. 
Keywords: Liver transplantation, brain death, gene expression profiling, ischemia/reperfusion injury. 
INTRODUCTION 
 Organs from brain dead donors are the main source for 
solid organ transplantation. Brain death (BD) is a complex 
physiological event, defined as an irreversible injury of 
cerebrum, cerebellum and brain stem and is associated with 
severe hemodynamic changes, coagulopathies, pulmonary 
changes, hypothermia and electrolyte imbalances. Hemody-
namic instability associated with brain death can contribute 
to deterioration of peripheral organs. These changes may 
predispose the graft to increasing ischemia reperfusion injury 
(IRI) damages during the transplant process, accelerating 
organ rejection after transplantation [1]. The hemodynamic 
instability is well recognized as ‘autonomic storm’, an initial 
period of excessive parasympathetic activity, which is imme-
diately followed by a sympathetic activation with high  
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plasma levels of catecholamines, extreme arterial hyperten-
sion and tachycardia. During these phases, potential donor 
grafts undergo a transient period of ischemia [2]. Shock and 
oxidative injury during the intensive care treatment of the 
potential donor, followed by brain death, should be regarded 
as a major risk factor affecting organ viability, post-trans-
plant function and graft survival in organ transplantation, in 
addition to unavoidable IRI during transplantation proce-
dures. Donor’s brain death might cause and promote organ 
injury altering the immunological and inflammatory status of 
the graft, increasing both the sensitivity of the organs to-
wards preservation injury and acute rejection following 
transplantation. Despite this correlation has been experimen-
tally shown, no clinical trials support so far this hypothesis 
[2]. 
 In a previous study [3] we have compared gene expres-
sion levels in transplanted livers, soon after reperfusion, 
versus basal gene expression levels, before liver retrieval 
from the donor. About 800 genes were found dysregulated 
after transplantation, but we have not analyzed the potential 
effects of brain death on the gene expression variations. 
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 A very recent study [4] compares gene expression pat-
terns of transplanted livers from living donors with trans-
planted livers from deceased donors, defining molecular 
signature of both. The authors focus their attention to the 
pathways, which show dysregulation in the transplant pro-
cess both in livers from living donors and from deceased 
donors; however they do not analyze the basal differences 
between the grafts from the two groups of donors. 
 The aim of the present study was to systematically define 
alterations of gene expression and impairment of specific 
pathways induced in deceased donor livers when compared 
to control livers. Based on these alterations an accurate 
analysis of genes dysregulated in transplanted livers versus 
control livers was carried out, in order to discriminate 
between transcriptional changes, due to ischemia reperfusion 
injuries, and variations possibly caused by brain death and 
other donor conditions. 
 We have compared gene expression profile of both 
deceased donor livers (DL) and transplanted livers (TL) to 
gene expression data of liver tissue, retrieved from Array 
Express database, used as control (CL) [3, 5]. This control 
was a set of livers from sudden death individuals without 
previous agonal state. Literature data demonstrate that the 
integrity of mRNA is scarcely affected by sudden death 
without agonal state. In contrast agonal state preceding death 
has a substantial effect on gene expression [6, 7]. A very 
large amount of research studies have been conducted on 
deceased tissues and also information included in all the 
databases reporting normal gene expression throughout the 
tissues [8] is derived from autoptic studies. 
 The expression of about 900 genes was found dysregu-
lated in DL if compared to controls. This wide gene expres-
sion modification clearly affects gene regulation in TL. 
 The data reported in the present study give new insight to 
clarify the consequences of brain death and intensive care 
injuries on the human orthotopic liver transplantation by a 
molecular point of view, and help us to recognize new ther-
apeutic targets useful to improve orthotopic liver transplanta-
tion (OLT) performance.  
MATERIALS AND METHODOLOGY 
Experimental Design 
 Gene expression profile of samples from DL and TL was 
compared to gene expression profile of samples from CL. 
The choice of sample size was performed by running p-
values of expression data comparisons among groups 
through the PowerAtlas software [9, 10]. We selected a 
sample size of ‘5’ per group to obtain an Expected Discovery 
Rate (EDR) > 40% (63%) and a True Positive Probability 
(TP) > 80% (98%) (Supplementary file 1). 
 Then, five biological replicates per condition were ana-
lyzed. All expression data (DL, TL and CL) were obtained 
by microarray analysis, using Affymetrix gene chip HG-
U133 Plus 2. Hybridization data were normalized and 
quantified using Robust Multiarray Analysis (RMA) soft-
ware [11]. DL and TL samples were collected as previously 
described [3]. Briefly, 10 liver biopsies were analyzed: 5 
biopsies, from the donors, collected before explantation (DL 
group); 5 biopsies from the transplant recipients (TL group), 
collected 2-3 hours after liver reperfusion. Donors were 
classified as ’standard’ according to the criteria of the 
’Italian National Transplantation Center’. Particularly, the 
donors’ age ranged from 38 to 83 years, no hypotension, 
steatosis always less than 15%. Mean cold ischemia time 
was 8 hours (ranging from seven to ten hours), mean warm 
ischemia 45 min, mean hospitalization in intensive care unit 
was 5 days [3]. Expression data of livers, from five healthy 
individuals who suffered sudden death, were retrieved from 
Array Express database (SAMPLE ID: E-AFMX-11) [5, 12] 
and used as control samples. All individuals, 3 males and 2 
females, suffered sudden death for reason other than their 
participation to the study and without any relation to the 
tissues used. Age was ranging from 27 to 29 and was 
unknown in 2 cases. Total RNAs, isolated from 200 mg of 
frozen tissues using the Trizol reagent, were of high and 
comparable quality as gauged by the ratio of 28S to 18S 
ribosomal RNAs estimated using the Agilent 2100 
Bioanalyzer (range 1.4-1.6) [12]. 
 In order to validate the use of deceased tissues as con-
trols, we compared our results to a set of expression data 
from microarray analysis (same technology and experimental 
conditions) of six liver biopsies from living donors, available 
very recently from GEO repository [4, 13] (Supplementary 
file 2). 
RNA Extraction, Data Acquisition and Analysis 
 DL and TL samples were treated as previously described 
[3]. Array data have been deposited in GEO data base with 
accession number GSE14951 [14]. Expression data were 
pre-filtered to reduce noise and discard ‘unreliable’ genes 
using the Cross-Gene error model [14]. The analysis of func-
tional clusters was performed on lists of differentially exp-
ressed genes for both Gene Ontology (GO) categories and 
biological pathways. GO functional class scoring was per-
formed using the web-based GOTM software [15, 16] which 
visualizes differential expressed genes in the GO context, 
considering as gene sets all the GO categories for biological 
processes, molecular functions and cellular components. The 
list of differentially expressed genes was compared to the 
complete list of genes spotted on Affymetrix HG-U133 Plus 
2 chip, in order to identify GO categories of genes signi-
ficantly (p < 0.01) more represented in the list of differ-
entially expressed genes than in the reference gene set. 
Real-Time Quantitative PCR 
 Expression values of 26 genes chosen among the most 
dysregulated genes were checked by RT-PCR. The same 
batch of total mRNA was used for both microarray and 
validation experiments in DL and TL. RNAs, from five liver 
tissue obtained during resection of benign focal lesions, were 
used as controls in RT-PCR experiments. Two biopsies came 
from liver resections of two females (24 and 26 aged) 
suffering by hepatocellular adenoma. Two biopsies came 
from liver resections of giant hepatic cystis from two male 
aged respectively 39 and 43. The last biopsy came from a 
liver of a male suffering by liver hemangioma. cDNA was 
synthesized Real Time PCR were performed as previously 
described [3]. PCR reactions were performed in triplicate. 
The primers (Primm Biotech Products and Services, Milan - 
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Italy) used for amplification are listed in Table 1. Primer 
pairs were designed using the Primer 3 software [17] in order 
to obtain amplicons ranging from 100 and 150 bp, and 
specifically designed to span introns or cross intron/exon 
boundaries. Data normalization was performed using 
GAPDH as housekeeping gene [18]. Experiments were 
performed twice, in triplicate. The amplification protocol 
was: 1 cycle of 10 min at 95 °C, 40 cycles of 95 °C for 15 
sec, 58-60 °C for 20 sec, 72 °C for 20 sec, plus an extension 
at 72 °C for 3 min. The relative expression value was 
calculated with the formula 2DDct 
Statistics 
 Expression data from different groups were compared 
using the ANOVA test, with Benjamini and Hochberg false 
discovery rate as multiple testing corrections. Statistical sig-
nificance was established at p < 0.01. Genes were considered 
differentially expressed with a fold change > 1.5 between 
two conditions. Gene sets were considered enriched with a p 
< 0.01 when compared to the reference gene list. 
 Liver biopsies were collected in different hospitals, inc-
luding the “Liver Transplantation Center” of the “Cardarelli 
Hospital”. All biopsies were obtained with informed consent 
given according to protocols approved by the Institutional 
Ethics Committee of the “Antonio Cardarelli Hospital.” 
RESULTS 
 The expression of about 33,000 genes, represented on the 
Affymetrix chip HG-U133 Plus 2, has been evaluated in 
liver samples from three groups: DL, TL 2 hours after reper-
fusion, and CL. The groups were compared each other for 
gene expression. Expression of about 900 genes was dys-
regulated in DL compared to control ones. Table 2 shows the 
40 most up-regulated and the 40 most down-regulated genes. 
Table 3a and Table 3b report the distribution of the dys- 
 
Table 1. Primer Pairs Used for Real-Time Quantitative PCR 
 
Probe Set Gene Name Ensembl Gene ID Left Primer Right Primer 
205364_at ACOX2 ENSG00000168306 CGGAGTCTTCAGGACCACAC GCAGGAAGCCATTGTCTGTT 
231587_at APOC3 ENSG00000110245 CAGCCCCGGGTACTCCTT TTGGTGGCGTGCTTCATGTA 
209186_at ATP2A2 ENSG00000174437 TGAAACAGTTCATCCGCTACC AATCAAAGCCTCGGGAAATC 
228876_at BAIAP2L2 ENSG00000128298 AGAACGTGCGGGAGATGAAG CAGACACGAAGGCCTGCAT 
212952_at CALR ENSG00000179218 CCTGAGTACAAGGGTGAGTGGAA GCCCAGCACGCCAAAGT 
204093_at CCNH ENST00000256897 CAGAAGTTGGAGCGATGTCA GTCCATTCTTCCTCCTCATGTT 
220046_s_at CCNL1 ENSG00000163660 GAACTCCAGCCCTTTCAACC TTGGTGATTTCTCTTCAGCTTTT 
228766_at CD36 ENSG00000135218 GCTGAGGACAACACAGTCTCTTTC AGCCTCTGTTCCAACTGATAGTGA 
213279_at DHRS1 ENSG00000157379 TGGCCGTGGCATTGC AGATGGCGGCCAGTGATG 
1555612_s_at G6PC ENSG00000131482 TCCGTCAGTGTCATCCCCTACT CCGAAGACTCCACATCTCTTACAA 
210328_at GNMT ENSG00000124713 ATCATCGCAACTACGACCACAT GTCCTTGGTCAAGTCACTCTTATAGTAGAT 
215554_at GPLD1 ENSG00000112293 GGGACCAGTGACTGCAACCT GCCCTGGGTGTGGTTTTG 
241945_at HECTD1 ENSG00000092148 ACTAATGCCACGAACAACATGAAT TGATGTAGTACCAGGTGTGGTCAA 
201466_s_at JUN ENSG00000177606 AGAAAGTCATGAACCACGTTAACAGT CCCCCGACGGTCTCTCTT 
205222_at LBP ENSG00000129988 CCGACTGACCACCAAGTCCTT GGCACTGATCCCTGGAGTTC 
203675_at NUCB2 ENSG00000070081 GAAAAGGCAAGAAGTAGGAAGGTT GTCAGGATTCAGGTGGTTTAGG 
206278_at PTAFR ENSG00000169403 CCTGCCACTTTGGATTGTCTACT GCCACGTTGCACAGGAATTT 
210479_s_at RORA ENSG00000069667 TCATTCTCCACCCAGCTGTTG CTGTGCTTTGCCCCAGTGTA 
222226_at SAA3P ENSG00000166787 GCCAGGCTACCAACAAATGG GCAGATTGAAAAGGAAGCTCAGTAT 
213874_at SERPINA4 ENSG00000100665 TCAAAGCCCTGTGGGAGAAA CGGACTGTTGTGTTCTCATCAAC 
222705_s_at SLC25A15 ENSG00000102743 CAGCCGCCGGTTCCTT ACACTGTATTCTGGCTCTTGGCTAT 
215223_s_at SOD2 ENSG00000112096 TGGTGGTGGTCATATCAATCA GCCGTCAGCTTCTCCTTAAA 
217040_x_at SOX15 ENSG00000129194 CAGCGGATTTTGCATTCGA GCTTAAACCGGAGCCTTTGC 
207306_at TCF15 ENSG00000125878 CCAGAGGGTATGTGTTGAAAAGTCT CCCTAGGCTGCTTGCAGAGA 
201042_at TGM2 ENSG00000198959 CTTTGACGTCTTTGCCCACAT CGGTGCGGGCACAGA 
239818_x_at TRIB1 ENSG00000173334 GGGCGCTGTGCATCCA AAGGCCTGATTTTGTCCTGGTA 
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Table 2. The Most up- and Down-Regulated Genes in DL Group vs. CL Group 
 
Up-Regulated Genes Down-Regulated Genes 
Gene Name Fold Change Gene Name Fold Change 
SPINK1 95.29 LOC283130 0.0555 
APOC3 9.516 MALAT-1 0.0612 
RPS11 8.807 TF 0.084 
SOD2 7.177 KCNN2 0.0927 
PLEKHG5 6.343 ID2 0.106 
LOC440836 6.052 H19 0.112 
ATP2A2 5.483 CAT 0.116 
APOA1 5.461 GNMT 0.117 
TOMM40 5.194 G6PC 0.13 
SAP30L 5.043 CD36 0.131 
TMEFF2 5.042 RORA 0.135 
APOC2 4.937 C8orf4 0.139 
TMEM151 4.83 SLC6A1 0.145 
RBP4 4.765 HECTD1 0.146 
C9ORF44 4.72 KIAA0293 0.155 
FAM84A 4.72 C6orf71 0.159 
SLC39A8 4.689 GPLD1 0.164 
LTB4R2 4.59 TRIB1 0.168 
RP3-402G11.12 4.375 DKFZP586A0522 0.176 
RPS19 4.354 MBNL2 0.177 
PTAFR 4.323 SERPINA4 0.185 
TCF15 4.236 FGD4 0.186 
FTL 4.157 CYP3A5 0.19 
LBP 4.083 CYP3A4 0.195 
SAA3P 4.069 DHRS1 0.195 
TGM2 4.062 C10orf65 0.202 
BAIAP2L2 4.039 SLC25A15 0.203 
SOX15 3.996 JUN 0.204 
DLG4 3.995 RCL1 0.204 
SLC35C1 3.919 ZGPAT 0.204 
ELMOD2 3.911 DSIPI 0.207 
DDX54 3.9 KLF6 0.209 
AMBP 3.876 CYP26A1 0.21 
SCUBE1 3.874 NDUFS1 0.213 
SFXN4 3.865 AASS 0.218 
TAOK2 3.782 CYP4A11 0.218 
VWA1 3.779 TMEM16A 0.22 
SRCRB4D 3.744 BAAT 0.221 
ATF5 3.709 HGD 0.221 
BBC3 3.678 PSMAL 0.232 
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Table 3a. Enriched GO Categories of Genes Up-Regulated in Donor Livers versus Controls 
 
List Name Description Total Probes 
Expected By 
Chance Actual Enrichment P-Value 
Regulation of JNK 
cascade 
Any process that modulates the frequency, rate or extent 
of signal transduction mediated by the JNK cascade 37 1.06 8 7.51 0.00000859 
DNA damage response, 
signal transduction by 
p53 class mediator 
A cascade of processes induced by the cell cycle 
regulator phosphoprotein p53, or an equivalent protein, in 
response to the detection of DNA damage 
44 1.27 8 6.32 0.00003298 
DNA damage response, 
signal transduction 
resulting in induction 
of apoptosis 
A cascade of processes initiated by the detection of DNA 
damage and resulting in the induction of apoptosis 
(programmed cell death) 
48 1.38 7 5.07 0.00042682 
Regulation of binding 
Any process that modulates the frequency, rate or extent 
of binding, the selective interaction of a molecule with 
one or more specific sites on another molecule 
59 1.70 7 4.12 0.00150276 
Stress-activated protein 
kinase signaling 
pathway 
A series of molecular signals in which a stress-activated 
protein kinase (SAPK) cascade relays one or more of the 
signals 
136 3.91 15 3.83 0.00000995 
JNK cascade 
A cascade of protein kinase activities, culminating in the 
phosphorylation and activation of a member of the JUN 
kinase subfamily of stress-activated protein kinases 
130 3.74 14 3.74 0.00002546 
DNA damage response, 
signal transduction 
A cascade of processes induced by the detection of DNA 
damage within a cell 115 3.31 12 3.63 0.00012753 
Induction of apoptosis 
by intracellular signals 
Any process induced by intracellular signals that directly 
activates any of the steps required for cell death by 
apoptosis 
82 2.36 8 3.39 0.00252772 
 
Table 3b. Enriched GO Categories of Genes Down-Regulated in Donor Livers versus Controls 
 
List Name Description Total Probes 
Expected 
by Chance Actual Enrichment p-Value 
Heterocycle metabolic 
process 
The chemical reactions and pathways involving 
heterocyclic compounds, those with a cyclic 
molecular structure and at least two different atoms in 
the ring (or rings) 
146 3.93 17 4.33 0.00000050 
Monocarboxylic acid 
metabolic process 
The chemical reactions and pathways involving 
monocarboxylic acids, any organic acid containing 
one carboxyl (COOH) group or anion (COO-) 
396 10.65 41 3.85 0.00000000 
Fatty acid metabolic process 
The chemical reactions and pathways involving fatty 
acids, aliphatic monocarboxylic acids liberated from 
naturally occurring fats and oils by hydrolysis 
283 7.61 29 3.81 0.00000000 
Aromatic compound 
metabolic process 
The chemical reactions and pathways involving 
aromatic compounds, any organic compound 
characterized by one or more planar rings, each of 
which contains conjugated double bonds and 
delocalized pi electrons 
211 5.68 20 3.52 0.00000142 
Sterol metabolic process 
The chemical reactions and pathways involving 
sterols, steroids with one or more hydroxyl groups 
and a hydrocarbon side-chain in the molecule 
147 3.95 13 3.29 0.00018779 
Electron transport The transport of electrons from an electron donor to an electron acceptor 599 16.11 48 2.98 0.00000000 
Alcohol metabolic process 
The chemical reactions and pathways involving 
alcohols, any of a class of alkyl compounds 
containing a hydroxyl group 
541 14.55 39 2.68 0.00000005 
Glucose metabolic process 
The chemical reactions and pathways involving 
glucose, the aldohexose gluco-hexose, D-glucose is 
dextrorotatory and is sometimes known as dextrose 
195 5.25 14 2.67 0.00090344 
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regulated genes in GO biological process categories, show-
ing that apoptosis and stress activated protein kinase acti-
vities are the most affected pathways by up-regulated genes 
(Table 3a), whereas down-regulated genes are involved in 
metabolic pathways and electron transport (Table 3b). At 
least 30 mitochondrial enzymes, involved in oxidative chain,  
are from 2 to 5 folds down-regulated, in deceased DL, if 
compared to CL (Table 4). Comparison between TL and CL 
samples demonstrated that 855 genes were dysregulated in 
TL versus CL. Condition tree from hierarchical clustering of 
these genes (Fig. 1) clearly shows that about 1/3 of these 
genes were already dysregulated in DL if compared to 
controls: 182 genes, (mainly involved in oxidoreductase, 
electron transport and metabolic activity), were already 
down-regulated in DL group versus CL group and 135 
genes, (involved in inflammatory pathways and cell adhe-
sion), were already up-regulated in DL group versus CL 
group. 
 In conclusion, the present study demonstrated that: 1) 
900 genes were dysregulated in DL if compared to controls; 
2) 855 genes were dysregulated in TL if compared to CL. At 
least 400 of these genes were already dysregulated in DL. 
 A comparison of expression data between biopsies of 
living donors and livers from sudden death individuals is 
shown in the supplemental section (Supplementary file 2). 
 Briefly, even though 217 genes are differentially 
expressed with fold change >1.75 and p<0.01 between livers 
Table 4. Oxidative Phosphorilation Genes Down-Regulated in Donor Livers versus Controls 
 
Gene Name Gene Bank Description Fold Change DL vs. CL 
AASS AK023446 aminoadipate-semialdehyde synthase 0.218 
ACOX1 BF435852 acyl-Coenzyme A oxidase 1, palmitoyl 0.296 
ACOX3 BF055171 acyl-Coenzyme A oxidase 3, pristanoyl 0.534 
ALDH5A1 NM_001080 aldehyde dehydrogenase 5 family, member A1 0.336 
CAT AW015521 catalase 0.266 
CHDH AA609488 choline dehydrogenase 0.493 
COX15 AF026850 COX15 homolog, cytochrome c oxidase assembly protein (yeast) 0.358 
COX7A2L NM_004718 cytochrome c oxidase subunit VIIa polypeptide 2 like 0.547 
CYP26A1 NM_000783 cytochrome P450, family 26, subfamily A, polypeptide 1 0.21 
CYP2B7 M29873 cytochrome P450, family 2, subfamily B, polypeptide 7 pseudogene 0.349 
CYP3A4 AV650252 cytochrome P450, family 3, subfamily A, polypeptide 4 0.195 
CYP3A43 NM_022820 cytochrome P450, family 3, subfamily A, polypeptide 43 0.305 
CYP3A5 AW964006 cytochrome P450, family 3, subfamily A, polypeptide 5 0.19 
CYP3A7 AF315325 cytochrome P450, family 3, subfamily A, polypeptide 7 0.297 
CYP4A11 BC041158 cytochrome P450, family 4, subfamily A, polypeptide 11 0.218 
DAO NM_001917 D-amino-acid oxidase 0.499 
FLJ22378 NM_025078 hypothetical protein FLJ22378 0.524 
HAO2 NM_016527 hydroxyacid oxidase 2 (long chain) 0.322 
IBRDC2 AI953847 IBR domain containing 2 0.502 
IVD NM_002225 isovaleryl Coenzyme A dehydrogenase 0.488 
KMO NM_003679 kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) 0.291 
NDUFA2 BC003674 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa 0.514 
NDUFB7 NM_004146 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa 0.376 
NDUFB8 AA723057 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa 0.455 
NDUFV1 AF092131 NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa 0.504 
NISCH NM_007184 nischarin 0.549 
PAOX AI743990 polyamine oxidase (exo-N4-amino) 0.523 
PIPOX AF136970 pipecolic acid oxidase 0.437 
UQCRB BC005230 ubiquinol-cytochrome c reductase binding protein 0.437 
ZDHHC4 NM_018106 zinc finger, DHHC domain containing 4 0.556 
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from living donors and livers from deceased subjects (CL) 
only 54 (63 probe sets) out of these genes are included in the 
set of 900 genes we found differentially expressed in DL vs. 
CL.  
 Quantitative RT-PCR analysis of 26 genes, chosen 
among the most dysregulated genes, was carried out in order 
to validate the results of microarray analysis. The RT-PCR 
experiments confirm the microarray data for these genes. 
Correlation between quantitative RT-PCR and microarray 
data was satisfactory for all the tested genes (r > 0.85) (Table 
5). 
DISCUSSION 
 Clinical studies on humans have shown that allograft 
from unrelated living donors have better graft function and 
survival than allograft from deceased donors [19-21]. This 
difference could be attributed to the pathophysiological 
changes derived from brain death and donor condition more 
than to the influence of cold ischemia times [22-24]. 
 In this study we have demonstrated that brain death, 
together with other factors related to donor condition (shock, 
intensive care treatment, parenteral nutrition, etc.) causes the 
dysregulation of at least 900 genes in human liver tissue. The 
 
Fig. (1). Condition tree from hierarchical clustering of genes differentially expressed between TL and CL groups.  
Samples from each group are well clustered together according to the expression level of these genes. The figure shows that many genes (in 
the lower part of the graphic), differentially expressed between TL and CL, were already dysregulated in the DL. Therefore their 
dysregulation might be due to brain death more than to ischemia/reperfusion injury. The genes in the upper part of the tree are dysregulated 
only in TL group both versus CL and DL samples. 
Genes were considered differentially expressed with p < 0.01 using ANOVA test with Benjamini and Hochberg false discovery rate 
correction. 
CL=Control livers, DL=Donor livers, TL=Transplanted livers. 
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validation study (Supplementary file 2) demonstrates that 54 
of them (6/%) might be affected by the choice of deceased 
tissues, as they are already dysregulated between CL and 
living donor tissues. Subtraction of these genes from the set 
of 900 genes does not affect at all the following considera-
tions about injuries occurring in donor livers. Up-regulated 
genes are mainly involved in immune response, cytoskeletal 
remodelling, inflammation, apoptosis and cell adhesion. 
Down-regulated genes are mostly involved in mitochondrial 
activities and metabolism, being members of metabolic 
pathways of aminoacids, such as Gly, Ser and Cys, fatty 
acids (HNF4alpha) and vitamins. Metabolism might be also 
affected by starvation and stress, due to a long stay in inten-
sive care unit. Molecular and cellular alterations triggered by 
brain death itself may significantly alter both early and long-
term results of transplantation if compared to organs 
harvested from living donors [25]. 
 Apoptosis induction and increased expression of apop-
tosis related proteins were observed in hepatocytes from 
brain dead animals [26]. A recent study on molecular 
changes induced in the heart by brain death [27], evaluates 
the variation in the expression levels of 5 genes involved in 
apoptotic processes: BAX, BCL2, CASP3, Cytochrome C 
(CYCS) and FAS and one gene induced by hypoxia (HIF1A) 
concluding that brain death mainly induces the expression of 
3 out of these genes: BAX, FAS and CASP3 involved in 
apoptosis activation. HIF1A is not significantly induced, 
excluding hypoxic damages. Our results show that BAX and 
FAS are induced in liver samples from deceased donors. 
Moreover in our experiments the anti-apoptotic BCL2 gene 
is induced much more than in the heart as like as HIF1A, 
indicating that hypoxic injuries are already present in DL.  
 Our study unraveled that in deceased DL at least 30 mito-
chondrial enzymes, involved in oxidative chain, are from 2 
to 5 fold down-regulated if compared to CL (Table 4). It is 
known that during ischemia oxidative phosphorylation and 
ATP level decrease producing ischemic damage. The 
Table 5.  Comparison between Quantitative Real Time PCR and Microarray Data 
 
Probe Set Gene Name Microarray Fold Change DL/CL RT Fold Change DL/CL 
205364_at ACOX2 acyl-Coenzyme A oxidase 2 0.27 0.27 
231587_at APOC3 apolipoprotein C-III 9.51 14.25 
209186_at ATP2A2 ATPase, Ca++ transporting 5.48 1.90 
228876_at BAIAP2L2 BAI1-associated protein 2-like 2 4.04 3.50 
212952_at CALR calreticulin 9.41 21.75 
204093_at CCNH cyclin H 1.06 0.90 
220046_s_at CCNL1 cyclin L1 0.47 0.30 
228766_at CD36 CD36 molecule  0.13 0.25 
213279_at DHRS1 dehydrogenase/reductase  0.20 0.28 
1555612_s_at G6PC glucose-6-phosphatase  0.13 0.08 
210328_at GNMT glycine N-methyltransferase  0.12 0.30 
215554_at GPLD1 glycerol-3-phosphate dehydrogenase 1 0.16 0.28 
241945_at HECTD1 HECT domain-containing 1 0.15 0.34 
201466_s_at JUN jun oncogene 0.20 0.18 
205222_at LBP lipopolysaccharide binding protein 4.08 6.55 
203675_at NUCB2 nucleobindin 2 3.95 3.90 
206278_at PTAFR platelet-activating factor receptor 4.32 7.80 
210479_s_at RORA RAR-related orphan receptor A 0.14 0.33 
222226_at SAA3P serum amyloid A3 pseudogene 4.07 6.05 
213874_at SERPINA4 serpin peptidase inhibitor 0.19 0.20 
222705_s_at SLC25A15 solute carrier family 25 0.20 0.65 
215223_s_at SOD2 superoxide dismutase 2 2.04 2.40 
217040_x_at SOX15SRY (sex determining region Y)-box 15 4.00 5.50 
207306_at TCF15 transcription factor 15 (basic helix-loop-helix) 4.24 7.45 
201042_at TGM2 transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) 4.06 4.65 
239818_x_at TRIB1 Tribless homolog 1 (Drosophila m.) 0.17 0.10 
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situation might be deeply compromised if the expression of 
oxidative enzymes is down-regulated. 
 A detailed analysis of 795 genes previously found dysre-
gulated in TL when compared to DL [3], in the new pers-
pective of the comparison between transplanted and control 
liver tissues shows that about 250 genes, mainly involved in 
angiogenesis, lipid metabolism, growth, cell cycle, were not 
confirmed as dysregulated in our study when compared to 
CL (Fig. 2). For these genes we hypothesize that their dys-
regulation is due to events related to brain death instead of 
IRI. However many genes reported as dysregulated in the 
previous study are dysregulated even when TL are compared 
to CL: 87 of them were already slightly up-regulated in DL 
group. These genes are mainly apoptotic regulators, proteo-
lytic enzymes, chemokines, cytokines and stress responsive 
genes. Ninetythree more genes, down-regulated in DL, are 
essentially involved in growth, angiogenesis, mitosis initia-
tion, cell cycle regulation and metabolism. We demonstrate 
that c-FOS and c-JUN are down-regulated by brain death 
causing inhibition of cell proliferation and VEGF signaling 
(angiogenesis). This might explain the better graft function 
and survival of allograft from living donors if compared to 
 
Fig. (2). Expression profiles of 795 genes previously found dysregulated in livers after transplant. 
The figure shows on the left the expression profiles of 538 genes found dysregulated in a previous study, in TL versus DL, and now 
confirmed as dysregulated in TL if compared to CL. Detailed analysis of these genes, dysregulated both versus DL and CL, shows three 
different behaviors: 
- 358 genes were normoregulated between DL and CL groups; 
- 87 genes were already slightly up-regulated in DL group. 
- 93 genes were down-regulated in DL group versus CL group and highly up-regulated after transplantation in TL group. 
On the right side of the figure are shown expression profiles of 257 genes dysregulated in TL versus DL, but not confirmed as dysregulated 
in TL when compared to CL. 
Genes were considered differentially expressed with p < 0.01 using ANOVA test with Benjamini and Hochberg false discovery rate 
correction. 
CL=Control livers, DL=Donor livers, TL=Transplanted livers. 
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deceased donors. All these genes are very highly up-
regulated after transplantation and reperfusion. 
 In addition to the genes already found dysregulated in the 
previous study and confirmed in this study, we found 317 
additional genes differentially expressed between TL and CL 
(Fig. 1); these genes were not detected in our previous study 
[3] because they were already dysregulated in DL, therefore 
no differences between DL and TL group were detectable. In 
detail, 135 genes were equally up-regulated in DL and TL 
group versus controls. They are mainly anti-apoptotic genes, 
NFKB subunits, BCL2, BCLXL, cell adhesion molecules. 182 
genes were equally down-regulated in DL and TL group 
versus controls. Most of them are involved in fatty acid, 
glucose and aminoacid metabolism and electron transport 
activities. Thus, inflammatory processes and oxidative 
phosphorylation activities are impaired in the liver since the 
pre-explant period, and continue to be impaired after 
transplant and reperfusion. 
 Functional analysis of the remaining genes dysregulated 
in TL group versus CL group completely confirms the 
results of our previous study [3]. Many authors agree with 
the idea that understanding molecular bases of graft failure is 
crucial to identify therapeutic targets able to improve 
transplant performance [28]. In this respect, a recent study 
identifies 78 classifier genes whose dysregulation after liver 
transplantation is able to predict initial poor graft function 
(IPGF) [29]. Our study demonstrated that 15 of these genes 
resulted already dysregulated in DL (Table 6); molecular 
pathways involved in IPGF might be compromised before 
the organ is explanted and preventing these mechanisms in 
the donors possibly results in better graft function. 
 Recently De Jonge et al. [4] have been carried out in 
human OLT a study which analyzes the differential gene  
 
expression between donor baseline biopsies and post-
reperfusion biopsies in two groups of liver transplantations: 
from living donors and from deceased donors. The authors 
find a large number of genes differentially expressed in both 
graft types following reperfusion when compared to the pre 
biopsies, more in the living transplant than in the deceased 
one. Among the group of genes differentially expressed in 
post-reperfusion biopsies of both groups they find a signi-
ficant up-regulation of genes involved in inflammatory and 
immune processes, both in deceased and in living donor 
grafts. 
CONCLUSIONS 
 Brain death and intensive care injuries induce stress in 
DL, affecting liver gene transcriptional profile both in 
donors and in recipients, and many genes dysregulated in TL 
versus CL are already dysregulated in DL before transplan-
tation. On these bases we hypothesize that the dysregulation 
of these genes, mainly involved in inflammatory pathways, 
cell adhesion and electron transport, might affect graft 
function and organ survival in OLT. The insight of these 
mechanisms is crucial for the identification of therapeutic 
targets, aiming to improve OLT performances. 
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Table 6.  15 Out of 78 Genes Predictive for IPGF, Already Dysregulated in Donor Livers versus Controls 
 
Gene Name Gene Bank Description Fold Change DL vs. CL 
SOD2 R34841 Superoxide dismutase 2, mitochondrial 7.177 
FCAMR AW028140 FKSG87 protein 2.332 
STCH NM_006948 Stress 70 protein chaperone, microsome-associated, 60kDa 2.161 
SOD2 BF575213 Superoxide dismutase 2, mitochondrial 1.898 
ADAMTS1 AF060152 A disintegrin-like and metalloprotease  with thrombospondin type 1 motif, 1 1.892 
VNN2 NM_004665 Vanin 2 1.874 
OSGIN2 BC031054 Chromosome 8 open reading frame 1 1.807 
RAB31 BF510937 Homo sapiens transcribed sequences 1.802 
IL-7 NM_000880 Interleukin 7 1.708 
FLJ22684 NM_025048 Hypothetical protein FLJ22684 1.635 
IFI16 AF208043 Interferon, gamma-inducible protein 16 1.62 
NCOA7 AL035689 Nuclear receptor coactivator 7 1.564 
LCP1 AW205969 Homo sapiens transcribed sequences 1.54 
MAP4K4 NM_017792 Hypothetical protein FLJ20373 0.528 
BAAT NM_001701 Bile acid Coenzyme A: amino acid N-acyltransferase  0.221 
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ABBREVIATIONS 
BD = Brain death 
CL = Control Livers 
DL = Donor livers 
EDR = Expected Discovery Rate 
GO = Gene Ontology 
IRI = Ischemia Reperfusion Injury 
OLT = Orthotopic Liver Transplantation 
RMA = Robust Multiarray Analysis 
TL = Transplanted Livers 
SUPPLEMENTARY MATERIAL 
 Supplementary material is available on the publishers 
Web site along with the published article. 
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ABSTRACT 
Objective 
Partial or complete trisomies of short arm of chromosome 5 are rare chromosomal 
abnormalities. We report a prenatal case of trisomy 5p due to a de novo inverted duplication  
with subtelomeric deletion in a fetus with mild phenotype anomalies. The characterization of 
the present case and the correlation between genotype and phenotype might help to identify 
the critical region for more severe anomalies such as cardiopathy and cerebral anomalies 
described in large 5p duplications.  
Methods 
The diagnosis was made by standard and molecular cytogenetic techniques on fetal 
lymphocytes at 22 weeks of gestation following the discovery of ultrasonographic 
abnormalities. The fetus presented short femur, bilateral clubfoot, pielectasy, broad anterior 
fontanelle and facial dysmorphisms.  
Results 
Molecular cytogenetics investigations and CGH array revealed an inverted duplication of the 
short arm of chromosome 5 spanning from 5p13.1 to 5p15.33 with a 600kb deletion of 5pter.  
Conclusions 
The absence of heart and brain anomalies, that should be ultrasonographically evident at 22 
weeks of gestation, suggests that the critical region for severe abnormalities in 5p arm is 
smaller than the region previously described including only a portion of 5p13.1 band. 
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INTRODUCTION 
Trisomies of short arm of chromosome 5 are uncommon abnormalities. Less than 50 subjects 
with complete or partial duplications have been described in medical literature since 1964. 
For the majority of them, 5p duplications were generated from structural chromosomal 
rearrangements or were due to chromosome markers. Only three cases with inverted 
duplication of chromosome 5p with or without terminal deletion were described (Wang et al. 
2008; Cervera et al. 1999; Sreekantaiah et al. 1999). The extension of both the duplicated and 
the deleted regions is different in size  in all cases, including our case. On the contrary the 
phenotype features are very similar all over the cases. Since the first description of the 
trisomy 5p syndrome by Lejeune et al. in 1964, various clinical features associated with 
segmental aneusomy on chromosome 5p have been delineated (Avansino et al. 1999, 
Velagaleti et al. 2000). Patients with duplications spanning from 5p15.3 to 5p13.3 have mild 
and relatively indistinct phenotypes, while in presence of complete 5p  trisomy as well as 
proximal duplications to cytogenetic band 5p13, the phenotype is more severe. 
Our case is the first prenatal detection of 5p duplication, not involving other chromosomes, in 
a fetus with very mild phenotype anomalies. 
Case description 
A 26 year old gravida 3 para 2 woman was referred to our unit for prenatal diagnosis because 
of fetal malformations. The family history of both the mother and her husband was not 
remarkable. Ultrasonographic examination showed short femur, bilateral clubfoot, pielectasy 
and broad anterior fontanelle. Tridimensional sonography showed facial dysmorphisms such 
as low-set ears, exophthalmos and sloping forehead (fig.1). The association of multiple soft 
markers suggested the opportunity of a fetal karyotyping. Therefore a cordocentesis was 
performed at 22 weeks of gestation.  
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MATERIALS AND METHODS 
Karyotyping and FISH 
Fetal blood was cultured for 48hr in Chromosome Medium (Euroclone). Metaphase 
chromosomes were analyzed by standard G-banding technique. FISH analysis was performed 
with the commercial probe LSI D5S23 for the Cri-du-Chat syndrome critical region 5p15.2 
and for whole chromosome 5 (wcp5,Vysis) according  to the manufacturer’s protocols. The 
5p15.33 region was hybridized with BAC clone probe RP11-94J21. BAC location was 
mapped according to UCSC Genome Bioinformatics (http://genome.ucsc.edu) and EMBL-
EBI and Sanger Institute Genome Database (http://www.ensembl.org). The BAC clone was 
extracted using standard methods (Birnboim 1993), labeled by random priming with CY3-
dCTP and hybridized as for the LSI probe. The analysis was performed on metaphases. Image 
acquisition was performed using an Olympus BX61 Microscope  with CytoVision 3.7 
software. 
Array CGH 
Comparative genomic hybridization (array-CGH) was performed using the Constitutional 
Chip® 4.0 including approximately 5000 BAC clones (PerkinElmer, USA) with a mean 500 
kb resolution. The array-CGH was performed in dye swap according to manufacturer’s 
instructions. The hybridization data were analyzed with OneClickCGH® software (Infoquant, 
UK). Control genome was a standard of female DNA (Promega). 
BACs-on-Beads (BoBs) tecnique 
BACs-on-BeadsTM is a technology where probes generated from selected BACs are 
immobilized onto Luminex encoded beads. The resulting bead sets are used to assay 
chromosomal gains and losses from minute amounts with high throughput. The assay was 
performed according to manufacturer’s instructions. The kit that we used gave information 
about 13, 18, 21, X and Y aneuploidies and about the 9 most frequent 
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microdeletion/duplication syndromes: Wolf-Hirschhorn, Cri-du-chat, Williams-Beuren, 
Langer-Giedion, Prader-Willi, Angelman, Miller-Dieker, Smith-Magenis, DiGeorge. One 
male and one female control genomes were used as reference samples. 
 
RESULTS 
CYTOGENETIC STUDIES 
BACs-on-Beads (BoBs) assay was performed within 48 hours on DNA extracted from fetal 
blood in order to quickly detect aneuploidies of chromosomes 13, 18, 21, X and Y, as well as 
copy number variations in 9 microdeletion syndrome regions. The BoBsoft software analysis 
showed that the whole Cri-du-Chat syndrome region was clearly duplicated (Fig. 2). Eight 
independent BAC probes are included in the BoBs panel for chromosome 5p, spanning 7,7 
Mb from 5p15.2 to 5p15.33.  
High resolution G banding of chromosomes from fetal lymphocytes showed additional 
material on the short arm of one chromosome 5 (Fig. 3). The whole chromosome painting for 
chromosome 5 (wcp5; Vysis) demonstrated that the additional material was derived from 
chromosome 5 only. No additional hybridization signals were seen on other chromosomes 
(Fig. 4). Dual FISH using both a Cri-du-Chat (Vysis) unique sequence (green signal), 
mapping to the p15.2 region of chromosome 5, and the BAC clone (red signal) mapping to 
p15.33 showed two fluorescent green signals on the short arm of the abnormal chromosome 
with a double red signal in between demonstrating that the duplication was inverted (Fig. 5). 
Array CGH with Constitutional Chip® 4.0 (Perkin Elmer) showed a 40 Mb duplication from 
5p13.1 to 5p15.33 with a 5pter deletion spanning about 600 Kb (Fig. 6). 
The complete karyotype formula was 46,XY,add(5)(p15.3).ish der(5)(5p1.3->5p1.5::5p1.5-
>5qter)(wcp5+,D5S23++,5ptel-).arr 5p15.33(RPI-24H17)x1, 5p15.33->5p13.1(RP11-94J21-
>CTD-2142G21)x3. 
 5 
DISCUSSION 
We have characterized, by molecular cytogenetics, the first prenatal case of inverted 
duplication with terminal deletion (inv dup del) of a large trait of the chromosome 5 short 
arm. FISH and CGH array analyses demonstrated that the duplication was inverted, spanning 
40Mb from 5p13.1 to 5p15.33, including the critical region for cri-du-chat syndrome. 
Furthermore there was a terminal deletion of about 600 kb.  
Our case did not involve other chromosomes and presented with very mild ultrasonographic 
anomalies. The comparison with three previously reported cases of invdup, with or without 
terminal deletion (Sreekantaiah et al. 1999, Cervera et al. 2005 and Wang et al. 2008), has 
shown that clinical features often found in these patients, like hypotonia, speech delay and 
mental retardation, are not assessable in prenatal diagnosis. Phenotypic characteristics 
associated with duplication involving chromosomal regions from 5p13.1 to centromere are, 
for example, congenital heart defect and brain abnormalities, not reported in our case even 
though a segment of 5p13.1 is duplicated. The absence of these severe anomalies, that should 
be ultrasonographically evident at 22 weeks of gestation, suggests that the critical region  for 
severe abnormalities in 5p arm is smaller than the region previously described (Velagaleti et 
al. 2000) and it includes only a portion of 5p13.1 band. 
It was hypothesized that inverted duplication with terminal deletion could arise from three 
mechanisms, all involving the formation of a dicentric chromosome which subsequently 
breaks during meiosis to form a monocentric duplicated and deleted chromosome. The most 
frequent mechanism, the “classical” model (Weleber et al. 1976, Jenderny et al. 1998), 
suggests that inv dup del occurs from an unusual intrachromosomal meiotic recombination in 
two homologous chromosomes after a double-strand break. This recombination process is 
called a U-type exchange because the ends of broken chromosomes fuse together and a 
dicentric chromosome is produced. After division one daughter cell contains a recombinant 
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chromosome with one centromere and a region with a symmetric inverted duplication 
accompanied by a concomitant distal deficiency together with the lack of telomeric 
sequences. 
Several studies on inverted 8p duplication/deletions have suggested a second mechanism 
identified as “modified” model (Gorinati et al., 1991; Minelli et al., 1993; Mitchell et al., 
1994; Guo et al., 1995; Floridia et al., 1996; Giglio et al., 2001; Shimokawa et al., 2004; 
Ciccone et al., 2006; Zuffardi et al., 2009). Abnormal meiotic alignment between two 
homologous chromosomes, followed by a non-allelic homologous recombination (NAHR), 
determine the formation of a dicentric chromosome. Subsequently, breakage of the dicentric 
outside the inverted repeats leads to a monocentric chromosome with a terminal deletion and 
an inverted duplication with a single copy region between duplication.  This mechanism 
involves the presence of inverted low-copy repeats (LCRs) spanning about 10-500kb, with a 
sequence homology greater than 95% (Stankiewicz et al. 2002, Rowe et al. 2009) outside the 
specific segment involved in the rearrangement. In case of tandem LCRs, Gorinati et al. 
(1991) suggest the possibility of a paracentric inversion in one parent. 
Two different couples of LCRs in tandem with high similarities in the breakpoint region of 
the described rearrangement (Fig. 7) support the hypothesis that in this case the mechanism of 
inv dup del 5p will be most likely consistent with the modified model. In this case a single 
copy region, spanning less than 50 kb, between LCRs in 5p15.33 might be identified only 
with a very high resolution array CGH (about 10 kb). 
Finally our study demonstrates the utility of a new technology, called “Bac-on-Beads”, that 
allows to quickly detect in 48hr the most frequent aneuploidies as well as many 
microdeletions and microduplications in prenatal diagnosis. 
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FIGURES 
Figure 1 
 
Ultrasonographic examination images of fetus showing bilateral clubfoot (A), pielectasy (B) 
and broad anterior fontanelle (C). Tridimensional sonography shows facial dysmorphisms 
such as low-set ears, exophthalmos and sloping forehead (D). 
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Figure 2 
 
Profile of the patient analyzed with BoBs, showing duplication of BAC clones in 5p15 (CDC 
probes). Patient DNA was compared to a female reference (in red) and to a male reference (in 
blue). The analysis showed a male karyotype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 11 
Figure 3 
                              
High resolution G-banding and ideogram of the derived chromosome 5 from fetal 
lymphocytes showing the presence of additional material on the short arm of one 
chromosome 5. 
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Figure 4 
 
Fluorescent In Situ Hybridization (FISH) performed on metaphases with whole chromosome 
painting for chromosome 5 showed that the additional material was derived from 
chromosome 5 only (red signals).   
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Figure 5 
  
Dual FISH using both a Cri-du-Chat unique sequence (green signal), mapping to the p15.2 
region of chromosome 5, and the RP11-94J21 BAC clone (red signal) mapping to p15.33 
showed two fluorescent green signals on the short arm of the abnormal chromosome 
(indicated by white arrow) with a double red signal in between demonstrating that the 
duplication was inverted. 
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Figure 6 
 
Array-CGH profile in dye swap of chromosome 5 showed a 40Mb duplication (green line) 
from 5p13.1 to 5p15.33 and a 5pter deletion spanning about 600kb (red line). 
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Figure 7 
 
 
Breakpoint region in 5p15.33 is indicated as red line. In this region, two different couples of 
LCRs in tandem with high similarity are located, supporting the hypothesis of a modified 
model. Yellow LCR region spans about 40kb while the gray one spans about 30kb. 
 
